05/01/2023 |
TACROLIMUS ANDA #065461 |
SUPPL-35 |
TACROLIMUS |
SANDOZ |
Labeling |
Approval |
05/01/2023 |
TACROLIMUS ANDA #065461 |
SUPPL-36 |
TACROLIMUS |
SANDOZ |
Labeling |
Approval |
05/01/2023 |
TACROLIMUS ANDA #065461 |
SUPPL-37 |
TACROLIMUS |
SANDOZ |
Labeling |
Approval |
05/01/2023 |
OLANZAPINE AND FLUOXETINE HYDROCHLORIDE ANDA #077742 |
SUPPL-19 |
FLUOXETINE HYDROCHLORIDE; OLANZAPINE |
PAR PHARM |
Labeling |
Approval |
05/01/2023 |
ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE ANDA #078244 |
SUPPL-6 |
ONDANSETRON HYDROCHLORIDE |
STERISCIENCE |
Labeling |
Approval |
05/01/2023 |
ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE ANDA #078244 |
SUPPL-8 |
ONDANSETRON HYDROCHLORIDE |
STERISCIENCE |
Labeling |
Approval |
05/01/2023 |
ONDANSETRON HYDROCHLORIDE ANDA #078257 |
SUPPL-6 |
ONDANSETRON HYDROCHLORIDE |
STERISCIENCE |
Labeling |
Approval |
05/01/2023 |
ONDANSETRON HYDROCHLORIDE ANDA #078257 |
SUPPL-8 |
ONDANSETRON HYDROCHLORIDE |
STERISCIENCE |
Labeling |
Approval |
05/01/2023 |
DESLORATADINE ANDA #078355 |
SUPPL-4 |
DESLORATADINE |
BELCHER PHARMS |
Labeling |
Approval |
05/01/2023 |
CLONAZEPAM ANDA #078654 |
SUPPL-11 |
CLONAZEPAM |
SUN PHARM INDS INC |
Manufacturing (CMC) |
Approval |
05/01/2023 |
TELMISARTAN ANDA #078710 |
SUPPL-7 |
TELMISARTAN |
CHARTWELL RX |
Manufacturing (CMC) |
Approval |
05/01/2023 |
IMIPRAMINE HYDROCHLORIDE ANDA #088262 |
SUPPL-36 |
IMIPRAMINE HYDROCHLORIDE |
STRIDES PHARMA |
Labeling |
Approval |
05/01/2023 |
IMIPRAMINE HYDROCHLORIDE ANDA #088276 |
SUPPL-36 |
IMIPRAMINE HYDROCHLORIDE |
STRIDES PHARMA |
Labeling |
Approval |
05/01/2023 |
IMIPRAMINE HYDROCHLORIDE ANDA #088292 |
SUPPL-36 |
IMIPRAMINE HYDROCHLORIDE |
STRIDES PHARMA |
Labeling |
Approval |
05/01/2023 |
MESALAMINE ANDA #091640 |
SUPPL-20 |
MESALAMINE |
ZYDUS PHARMS |
Labeling |
Approval |
05/01/2023 |
CABERGOLINE ANDA #202947 |
SUPPL-2 |
CABERGOLINE |
MYLAN |
Labeling |
Approval |
05/01/2023 |
DICLOFENAC POTASSIUM ANDA #202964 |
SUPPL-3 |
DICLOFENAC POTASSIUM |
PAR FORM |
Labeling |
Approval |
05/01/2023 |
NIFEDIPINE ANDA #202987 |
SUPPL-3 |
NIFEDIPINE |
NOVAST LABS |
Labeling |
Approval |
05/01/2023 |
LAPATINIB DITOSYLATE ANDA #203007 |
SUPPL-3 |
LAPATINIB DITOSYLATE |
NATCO PHARMA LTD |
Labeling |
Approval |
05/01/2023 |
FOSAPREPITANT DIMEGLUMINE ANDA #203939 |
SUPPL-2 |
FOSAPREPITANT DIMEGLUMINE |
SANDOZ |
Labeling |
Approval |
05/01/2023 |
FOSAPREPITANT DIMEGLUMINE ANDA #203939 |
SUPPL-3 |
FOSAPREPITANT DIMEGLUMINE |
SANDOZ |
Labeling |
Approval |
05/01/2023 |
DALFAMPRIDINE ANDA #206646 |
SUPPL-3 |
DALFAMPRIDINE |
HIKMA |
Labeling |
Approval |
05/01/2023 |
DALFAMPRIDINE ANDA #206646 |
SUPPL-4 |
DALFAMPRIDINE |
HIKMA |
Labeling |
Approval |
05/01/2023 |
DALFAMPRIDINE ANDA #206765 |
SUPPL-11 |
DALFAMPRIDINE |
ALKEM LABS LTD |
Labeling |
Approval |
05/01/2023 |
DALFAMPRIDINE ANDA #206811 |
SUPPL-9 |
DALFAMPRIDINE |
AUROBINDO PHARMA |
Labeling |
Approval |
05/01/2023 |
DALFAMPRIDINE ANDA #206863 |
SUPPL-3 |
DALFAMPRIDINE |
ACCORD HLTHCARE |
Labeling |
Approval |
05/01/2023 |
CLOBAZAM ANDA #208819 |
SUPPL-6 |
CLOBAZAM |
BIONPHARMA |
Labeling |
Approval |
05/01/2023 |
CLOBAZAM ANDA #209308 |
SUPPL-9 |
CLOBAZAM |
BRECKENRIDGE |
Labeling |
Approval |
05/01/2023 |
CLOBAZAM ANDA #209715 |
SUPPL-2 |
CLOBAZAM |
HIKMA |
Labeling |
Approval |
05/01/2023 |
CLOBAZAM ANDA #209795 |
SUPPL-4 |
CLOBAZAM |
HETERO LABS LTD III |
Labeling |
Approval |
05/01/2023 |
BIKTARVY NDA #210251 |
SUPPL-17 |
BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE |
GILEAD SCIENCES INC |
Labeling |
Approval |
05/01/2023 |
CLOBAZAM ANDA #210545 |
SUPPL-4 |
CLOBAZAM |
LUPIN LTD |
Labeling |
Approval |
05/01/2023 |
CLOBAZAM ANDA #210546 |
SUPPL-4 |
CLOBAZAM |
LUPIN LTD |
Labeling |
Approval |
05/01/2023 |
CLOBAZAM ANDA #211259 |
SUPPL-4 |
CLOBAZAM |
MYLAN |
Labeling |
Approval |
05/01/2023 |
CLOBAZAM ANDA #211711 |
SUPPL-4 |
CLOBAZAM |
MICRO LABS |
Labeling |
Approval |
05/01/2023 |
CLOBAZAM ANDA #211959 |
SUPPL-3 |
CLOBAZAM |
CELLTRION |
Labeling |
Approval |
05/01/2023 |
CLOBAZAM ANDA #212714 |
SUPPL-2 |
CLOBAZAM |
ALKEM LABS LTD |
Labeling |
Approval |
05/01/2023 |
CLOBAZAM ANDA #212714 |
SUPPL-4 |
CLOBAZAM |
ALKEM LABS LTD |
Labeling |
Approval |
05/01/2023 |
LUMRYZ NDA #214755 |
ORIG-1 |
SODIUM OXYBATE |
AVADEL CNS |
|
Approval |
05/01/2023 |
AMITRIPTYLINE HYDROCHLORIDE ANDA #215376 |
ORIG-1 |
AMITRIPTYLINE HYDROCHLORIDE |
RUBICON |
|
Approval |
05/01/2023 |
LETROZOLE;VRIBOCICLIB SUCCINATE ANDA #215975 |
ORIG-1 |
LETROZOLE;RIBOCICLIB SUCCINATE |
MSN LABS PVT LTD |
|
Tentative Approval |
05/01/2023 |
TIROFIBAN HYDROCHLORIDE ANDA #216379 |
ORIG-1 |
TIROFIBAN HYDROCHLORIDE |
EUGIA PHARMA |
|
Approval |
05/01/2023 |
METHSUXIMIDE ANDA #217213 |
ORIG-1 |
METHSUXIMIDE |
NOVITIUM PHARMA |
|
Approval |
05/01/2023 |
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE ANDA #217260 |
ORIG-1 |
DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE |
INGENUS PHARMS LLC |
|
Approval |
05/02/2023 |
PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER NDA #021703 |
SUPPL-23 |
CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE |
BAXTER HLTHCARE CORP |
Labeling |
Approval |
05/02/2023 |
PRISMASOL B22GK 2/2.5 IN PLASTIC CONTAINER NDA #021703 |
SUPPL-23 |
CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE |
BAXTER HLTHCARE CORP |
Labeling |
Approval |
05/02/2023 |
PRISMASOL B22GK 4/0 IN PLASTIC CONTAINER NDA #021703 |
SUPPL-23 |
CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE |
BAXTER HLTHCARE CORP |
Labeling |
Approval |
05/02/2023 |
PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER NDA #021703 |
SUPPL-23 |
CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE |
BAXTER HLTHCARE CORP |
Labeling |
Approval |
05/02/2023 |
PRISMASOL BGK 0/2.5 IN PLASTIC CONTAINER NDA #021703 |
SUPPL-23 |
CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE |
BAXTER HLTHCARE CORP |
Labeling |
Approval |
05/02/2023 |
PRISMASOL BGK 2/0 IN PLASTIC CONTAINER NDA #021703 |
SUPPL-23 |
CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE |
BAXTER HLTHCARE CORP |
Labeling |
Approval |
05/02/2023 |
PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER NDA #021703 |
SUPPL-23 |
CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE |
BAXTER HLTHCARE CORP |
Labeling |
Approval |
05/02/2023 |
PRISMASOL BGK 4/0 IN PLASTIC CONTAINER NDA #021703 |
SUPPL-23 |
CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE |
BAXTER HLTHCARE CORP |
Labeling |
Approval |
05/02/2023 |
PRISMASOL BGK 4/0/1.2 IN PLASTIC CONTAINER NDA #021703 |
SUPPL-23 |
CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE |
BAXTER HLTHCARE CORP |
Labeling |
Approval |
05/02/2023 |
PRISMASOL BGK 4/2.5 IN PLASTIC CONTAINER NDA #021703 |
SUPPL-23 |
CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE |
BAXTER HLTHCARE CORP |
Labeling |
Approval |
05/02/2023 |
PRISMASOL BGK 4/3.5 IN PLASTIC CONTAINER NDA #021703 |
SUPPL-23 |
CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE |
BAXTER HLTHCARE CORP |
Labeling |
Approval |
05/02/2023 |
PRISMASOL BK 0/0 IN PLASTIC CONTAINER NDA #021703 |
SUPPL-23 |
CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE |
BAXTER HLTHCARE CORP |
Labeling |
Approval |
05/02/2023 |
PRISMASOL BK 0/0/1.2 IN PLASTIC CONTAINER NDA #021703 |
SUPPL-23 |
CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE |
BAXTER HLTHCARE CORP |
Labeling |
Approval |
05/02/2023 |
PRISMASOL BK 0/3.5 IN PLASTIC CONTAINER NDA #021703 |
SUPPL-23 |
CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE |
BAXTER HLTHCARE CORP |
Labeling |
Approval |
05/02/2023 |
PRISMASOL BK 4/2.5 IN PLASTIC CONTAINER NDA #021703 |
SUPPL-23 |
CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE |
BAXTER HLTHCARE CORP |
Labeling |
Approval |
05/02/2023 |
ALPRAZOLAM ANDA #074174 |
SUPPL-15 |
ALPRAZOLAM |
NOVITIUM PHARMA |
Labeling |
Approval |
05/02/2023 |
DULOXETINE HYDROCHLORIDE ANDA #090745 |
SUPPL-4 |
DULOXETINE HYDROCHLORIDE |
SUN PHARM |
Labeling |
Approval |
05/02/2023 |
DULOXETINE HYDROCHLORIDE ANDA #090745 |
SUPPL-5 |
DULOXETINE HYDROCHLORIDE |
SUN PHARM |
Labeling |
Approval |
05/02/2023 |
DULOXETINE HYDROCHLORIDE ANDA #090745 |
SUPPL-10 |
DULOXETINE HYDROCHLORIDE |
SUN PHARM |
Labeling |
Approval |
05/02/2023 |
DULOXETINE HYDROCHLORIDE ANDA #090745 |
SUPPL-11 |
DULOXETINE HYDROCHLORIDE |
SUN PHARM |
Labeling |
Approval |
05/02/2023 |
DULOXETINE HYDROCHLORIDE ANDA #090745 |
SUPPL-12 |
DULOXETINE HYDROCHLORIDE |
SUN PHARM |
Labeling |
Approval |
05/02/2023 |
DULOXETINE HYDROCHLORIDE ANDA #090745 |
SUPPL-16 |
DULOXETINE HYDROCHLORIDE |
SUN PHARM |
Labeling |
Approval |
05/02/2023 |
DULOXETINE HYDROCHLORIDE ANDA #090745 |
SUPPL-19 |
DULOXETINE HYDROCHLORIDE |
SUN PHARM |
Labeling |
Approval |
05/02/2023 |
DULOXETINE HYDROCHLORIDE ANDA #090745 |
SUPPL-21 |
DULOXETINE HYDROCHLORIDE |
SUN PHARM |
Labeling |
Approval |
05/02/2023 |
DULOXETINE HYDROCHLORIDE ANDA #090745 |
SUPPL-26 |
DULOXETINE HYDROCHLORIDE |
SUN PHARM |
Labeling |
Approval |
05/02/2023 |
DULOXETINE HYDROCHLORIDE ANDA #090776 |
SUPPL-8 |
DULOXETINE HYDROCHLORIDE |
ACTAVIS ELIZABETH |
Labeling |
Approval |
05/02/2023 |
DULOXETINE HYDROCHLORIDE ANDA #090776 |
SUPPL-10 |
DULOXETINE HYDROCHLORIDE |
ACTAVIS ELIZABETH |
Labeling |
Approval |
05/02/2023 |
DULOXETINE HYDROCHLORIDE ANDA #090776 |
SUPPL-11 |
DULOXETINE HYDROCHLORIDE |
ACTAVIS ELIZABETH |
Labeling |
Approval |
05/02/2023 |
DULOXETINE HYDROCHLORIDE ANDA #090776 |
SUPPL-14 |
DULOXETINE HYDROCHLORIDE |
ACTAVIS ELIZABETH |
Labeling |
Approval |
05/02/2023 |
DULOXETINE HYDROCHLORIDE ANDA #090776 |
SUPPL-17 |
DULOXETINE HYDROCHLORIDE |
ACTAVIS ELIZABETH |
Labeling |
Approval |
05/02/2023 |
DULOXETINE HYDROCHLORIDE ANDA #090776 |
SUPPL-18 |
DULOXETINE HYDROCHLORIDE |
ACTAVIS ELIZABETH |
Labeling |
Approval |
05/02/2023 |
DULOXETINE HYDROCHLORIDE ANDA #202045 |
SUPPL-11 |
DULOXETINE HYDROCHLORIDE |
APOTEX |
Labeling |
Approval |
05/02/2023 |
DULOXETINE HYDROCHLORIDE ANDA #202045 |
SUPPL-13 |
DULOXETINE HYDROCHLORIDE |
APOTEX |
Labeling |
Approval |
05/02/2023 |
DULOXETINE HYDROCHLORIDE ANDA #202045 |
SUPPL-14 |
DULOXETINE HYDROCHLORIDE |
APOTEX |
Labeling |
Approval |
05/02/2023 |
DULOXETINE HYDROCHLORIDE ANDA #202045 |
SUPPL-16 |
DULOXETINE HYDROCHLORIDE |
APOTEX |
Labeling |
Approval |
05/02/2023 |
ESZOPICLONE ANDA #202929 |
SUPPL-27 |
ESZOPICLONE |
MACLEODS PHARMS LTD |
Labeling |
Approval |
05/02/2023 |
DULOXETINE HYDROCHLORIDE ANDA #203197 |
SUPPL-3 |
DULOXETINE HYDROCHLORIDE |
ALKEM LABS LTD |
Labeling |
Approval |
05/02/2023 |
DULOXETINE HYDROCHLORIDE ANDA #203197 |
SUPPL-4 |
DULOXETINE HYDROCHLORIDE |
ALKEM LABS LTD |
Labeling |
Approval |
05/02/2023 |
DULOXETINE HYDROCHLORIDE ANDA #203197 |
SUPPL-7 |
DULOXETINE HYDROCHLORIDE |
ALKEM LABS LTD |
Labeling |
Approval |
05/02/2023 |
DULOXETINE HYDROCHLORIDE ANDA #203197 |
SUPPL-11 |
DULOXETINE HYDROCHLORIDE |
ALKEM LABS LTD |
Labeling |
Approval |
05/02/2023 |
DULOXETINE HYDROCHLORIDE ANDA #203197 |
SUPPL-15 |
DULOXETINE HYDROCHLORIDE |
ALKEM LABS LTD |
Labeling |
Approval |
05/02/2023 |
DULOXETINE HYDROCHLORIDE ANDA #206653 |
SUPPL-7 |
DULOXETINE HYDROCHLORIDE |
PRINSTON INC |
Labeling |
Approval |
05/02/2023 |
DULOXETINE HYDROCHLORIDE ANDA #206653 |
SUPPL-8 |
DULOXETINE HYDROCHLORIDE |
PRINSTON INC |
Labeling |
Approval |
05/02/2023 |
DULOXETINE HYDROCHLORIDE ANDA #206653 |
SUPPL-9 |
DULOXETINE HYDROCHLORIDE |
PRINSTON INC |
Labeling |
Approval |
05/02/2023 |
DULOXETINE HYDROCHLORIDE ANDA #206653 |
SUPPL-10 |
DULOXETINE HYDROCHLORIDE |
PRINSTON INC |
Labeling |
Approval |
05/02/2023 |
PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER NDA #207026 |
SUPPL-8 |
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE |
BAXTER HLTHCARE CORP |
Labeling |
Approval |
05/02/2023 |
PHOXILLUM BK 4/2.5 IN PLASTIC CONTAINER NDA #207026 |
SUPPL-8 |
CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE |
BAXTER HLTHCARE CORP |
Labeling |
Approval |
05/02/2023 |
LUMIFY NDA #208144 |
SUPPL-15 |
BRIMONIDINE TARTRATE |
BAUSCH AND LOMB INC |
Manufacturing (CMC) |
Approval |
05/02/2023 |
CLOMIPRAMINE HYDROCHLORIDE ANDA #208632 |
SUPPL-6 |
CLOMIPRAMINE HYDROCHLORIDE |
AMNEAL PHARMS CO |
Labeling |
Approval |
05/02/2023 |
MOXIFLOXACIN HYDROCHLORIDE ANDA #208778 |
SUPPL-1 |
MOXIFLOXACIN HYDROCHLORIDE |
GLAND PHARMA LTD |
Labeling |
Approval |
05/02/2023 |
ERTAPENEM SODIUM ANDA #209145 |
ORIG-1 |
ERTAPENEM SODIUM |
SUN PHARM |
|
Approval |
05/02/2023 |
DULOXETINE HYDROCHLORIDE ANDA #210599 |
SUPPL-1 |
DULOXETINE HYDROCHLORIDE |
QINGDAO BAHEAL PHARM |
Labeling |
Approval |
05/02/2023 |
LEVOTHYROXINE SODIUM ANDA #211369 |
SUPPL-5 |
LEVOTHYROXINE SODIUM |
TEVA PHARMS USA INC |
Manufacturing (CMC) |
Approval |
05/02/2023 |
ELIGLUSTAT TARTRATE ANDA #212420 |
ORIG-1 |
ELIGLUSTAT TARTRATE |
UPSHER SMITH LABS |
|
Approval |
05/03/2023 |
TOPAMAX NDA #020505 |
SUPPL-65 |
TOPIRAMATE |
JANSSEN PHARMS |
Labeling |
Approval |
05/03/2023 |
TOPAMAX NDA #020844 |
SUPPL-56 |
TOPIRAMATE |
JANSSEN PHARMS |
Labeling |
Approval |
05/03/2023 |
TOPAMAX SPRINKLE NDA #020844 |
SUPPL-56 |
TOPIRAMATE |
JANSSEN PHARMS |
Labeling |
Approval |
05/03/2023 |
KALYDECO NDA #203188 |
SUPPL-38 |
IVACAFTOR |
VERTEX PHARMS |
Labeling |
Approval |
05/03/2023 |
KALYDECO NDA #207925 |
SUPPL-16 |
IVACAFTOR |
VERTEX PHARMS INC |
Efficacy |
Approval |
05/03/2023 |
CLOBAZAM ANDA #209808 |
SUPPL-2 |
CLOBAZAM |
PIRAMAL HLTHCARE UK |
Labeling |
Approval |
05/03/2023 |
ACETAMINOPHEN ANDA #215403 |
ORIG-1 |
ACETAMINOPHEN |
INFORLIFE |
|
Approval |
05/03/2023 |
SUCRALFATE ANDA #215705 |
ORIG-1 |
SUCRALFATE |
ZYDUS LIFESCIENCES |
|
Approval |
05/03/2023 |
SAFINAMIDE ANDA #215945 |
ORIG-1 |
SAFINAMIDE |
RK PHARMA |
|
Tentative Approval |
05/03/2023 |
EDETATE CALCIUM DISODIUM ANDA #216435 |
ORIG-1 |
EDETATE CALCIUM DISODIUM |
CASPER PHARMA LLC |
|
Approval |
05/03/2023 |
NICARDIPINE HYDROCHLORIDE ANDA #217555 |
ORIG-1 |
NICARDIPINE HYDROCHLORIDE |
BIONPHARMA |
|
Approval |
05/04/2023 |
SKYLA NDA #203159 |
SUPPL-14 |
LEVONORGESTREL |
BAYER HLTHCARE |
Labeling |
Approval |
05/04/2023 |
TOPIRAMATE ANDA #205976 |
ORIG-2 |
TOPIRAMATE |
PAR PHARM |
|
Approval |
05/04/2023 |
KYLEENA NDA #208224 |
SUPPL-5 |
LEVONORGESTREL |
BAYER HLTHCARE |
Labeling |
Approval |
05/04/2023 |
CINACALCET HYDROCHLORIDE ANDA #208368 |
SUPPL-3 |
CINACALCET HYDROCHLORIDE |
DR REDDYS |
Labeling |
Approval |
05/04/2023 |
SODIUM PHENYLACETATE AND SODIUM BENZOATE ANDA #208521 |
SUPPL-2 |
SODIUM BENZOATE; SODIUM PHENYLACETATE |
MAIA PHARMS INC |
Labeling |
Approval |
05/04/2023 |
ITRACONAZOLE ANDA #208591 |
SUPPL-9 |
ITRACONAZOLE |
ALKEM LABS LTD |
Labeling |
Approval |
05/04/2023 |
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE ANDA #211563 |
ORIG-1 |
DAPAGLIFLOZIN;METFORMIN HYDROCHLORIDE |
ALKEM LABS LTD |
|
Tentative Approval |
05/04/2023 |
LENALIDOMIDE ANDA #215759 |
ORIG-1 |
LENALIDOMIDE |
BIOCON PHARMA LTD |
|
Tentative Approval |
05/04/2023 |
MOTPOLY XR NDA #216185 |
ORIG-1 |
LACOSAMIDE |
AUCTA |
Type 3 - New Dosage Form |
Approval |
05/05/2023 |
IBUPROFEN ANDA #079205 |
SUPPL-5 |
IBUPROFEN |
MARKSANS PHARMA |
Labeling |
Approval |
05/05/2023 |
IBUPROFEN ANDA #079205 |
SUPPL-11 |
IBUPROFEN |
MARKSANS PHARMA |
Labeling |
Approval |
05/05/2023 |
HYDROXYCHLOROQUINE SULFATE ANDA #201691 |
SUPPL-7 |
HYDROXYCHLOROQUINE SULFATE |
ALKALOIDA ZRT |
Labeling |
Approval |
05/05/2023 |
LAMIVUDINE ANDA #202941 |
SUPPL-5 |
LAMIVUDINE |
APOTEX |
Labeling |
Approval |
05/05/2023 |
POTASSIUM CHLORIDE ANDA #203002 |
SUPPL-4 |
POTASSIUM CHLORIDE |
LUPIN LTD |
Labeling |
Approval |
05/05/2023 |
METOPROLOL SUCCINATE ANDA #203894 |
SUPPL-8 |
METOPROLOL SUCCINATE |
ZYDUS PHARMS |
Labeling |
Approval |
05/05/2023 |
METOPROLOL SUCCINATE ANDA #203894 |
SUPPL-10 |
METOPROLOL SUCCINATE |
ZYDUS PHARMS |
Labeling |
Approval |
05/05/2023 |
SIMBRINZA NDA #204251 |
SUPPL-12 |
BRIMONIDINE TARTRATE; BRINZOLAMIDE |
ALCON LABS INC |
Labeling |
Approval |
05/05/2023 |
CARIPRAZINE ANDA #213982 |
ORIG-1 |
CARIPRAZINE |
AUROBINDO PHARMA LTD |
|
Tentative Approval |
05/05/2023 |
MYDCOMBI NDA #215352 |
ORIG-1 |
PHENYLEPHRINE HYDROCHLORIDE; TROPICAMIDE |
EYENOVIA |
Type 5 - New Formulation or New Manufacturer |
Approval |
05/05/2023 |
METHYLNALTREXONE BROMIDE ANDA #216836 |
ORIG-1 |
METHYLNALTREXONE BROMIDE |
GLAND PHARMA LTD |
|
Tentative Approval |
05/08/2023 |
ZYRTEC ALLERGY NDA #019835 |
SUPPL-45 |
CETIRIZINE HYDROCHLORIDE |
J AND J CONSUMER INC |
Labeling |
Approval |
05/08/2023 |
ZYRTEC HIVES RELIEF NDA #019835 |
SUPPL-45 |
CETIRIZINE HYDROCHLORIDE |
J AND J CONSUMER INC |
Labeling |
Approval |
05/08/2023 |
RIBAVIRIN ANDA #077053 |
SUPPL-14 |
RIBAVIRIN |
HERITAGE PHARMA AVET |
Labeling |
Approval |
05/08/2023 |
RABEPRAZOLE SODIUM ANDA #078964 |
SUPPL-18 |
RABEPRAZOLE SODIUM |
CHARTWELL RX |
Labeling |
Approval |
05/08/2023 |
RABEPRAZOLE SODIUM ANDA #078964 |
SUPPL-20 |
RABEPRAZOLE SODIUM |
CHARTWELL RX |
Labeling |
Approval |
05/08/2023 |
LITHIUM CARBONATE ANDA #079139 |
SUPPL-12 |
LITHIUM CARBONATE |
GLENMARK PHARMS LTD |
Labeling |
Approval |
05/08/2023 |
DILANTIN ANDA #084427 |
SUPPL-45 |
PHENYTOIN |
PHARMACIA |
Labeling |
Approval |
05/08/2023 |
GLATOPA ANDA #090218 |
SUPPL-27 |
GLATIRAMER ACETATE |
SANDOZ |
Labeling |
Approval |
05/08/2023 |
VALACYCLOVIR HYDROCHLORIDE ANDA #090682 |
SUPPL-17 |
VALACYCLOVIR HYDROCHLORIDE |
AUROBINDO PHARMA |
Labeling |
Approval |
05/08/2023 |
VALACYCLOVIR HYDROCHLORIDE ANDA #090682 |
SUPPL-20 |
VALACYCLOVIR HYDROCHLORIDE |
AUROBINDO PHARMA |
Labeling |
Approval |
05/08/2023 |
CLOPIDOGREL BISULFATE ANDA #091023 |
SUPPL-20 |
CLOPIDOGREL BISULFATE |
DR REDDYS LABS LTD |
Labeling |
Approval |
05/08/2023 |
LINEZOLID ANDA #200068 |
SUPPL-7 |
LINEZOLID |
HIKMA |
Labeling |
Approval |
05/08/2023 |
LINEZOLID ANDA #200068 |
SUPPL-8 |
LINEZOLID |
HIKMA |
Labeling |
Approval |
05/08/2023 |
FARXIGA NDA #202293 |
SUPPL-26 |
DAPAGLIFLOZIN |
ASTRAZENECA AB |
Efficacy |
Approval |
05/08/2023 |
ATOMOXETINE HYDROCHLORIDE ANDA #202682 |
SUPPL-1 |
ATOMOXETINE HYDROCHLORIDE |
HETERO LABS LTD V |
Labeling |
Approval |
05/08/2023 |
BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE ANDA #202940 |
SUPPL-4 |
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE |
PHARM ASSOC |
Labeling |
Approval |
05/08/2023 |
MYCOPHENOLATE MOFETIL ANDA #203005 |
SUPPL-18 |
MYCOPHENOLATE MOFETIL |
ALKEM LABS LTD |
Labeling |
Approval |
05/08/2023 |
DILTIAZEM HYDROCHLORIDE ANDA #203023 |
SUPPL-10 |
DILTIAZEM HYDROCHLORIDE |
SUN PHARM |
Labeling |
Approval |
05/08/2023 |
MORPHINE SULFATE ANDA #206573 |
SUPPL-2 |
MORPHINE SULFATE |
PHARM ASSOC |
Labeling |
Approval |
05/08/2023 |
MORPHINE SULFATE ANDA #206573 |
SUPPL-4 |
MORPHINE SULFATE |
PHARM ASSOC |
Labeling |
Approval |
05/08/2023 |
MORPHINE SULFATE ANDA #206573 |
SUPPL-6 |
MORPHINE SULFATE |
PHARM ASSOC |
Labeling |
Approval |
05/08/2023 |
MORPHINE SULFATE ANDA #206573 |
SUPPL-8 |
MORPHINE SULFATE |
PHARM ASSOC |
Labeling |
Approval |
05/08/2023 |
MORPHINE SULFATE ANDA #206573 |
SUPPL-10 |
MORPHINE SULFATE |
PHARM ASSOC |
Labeling |
Approval |
05/08/2023 |
DEXMETHYLPHENIDATE HYDROCHLORIDE ANDA #206931 |
SUPPL-6 |
DEXMETHYLPHENIDATE HYDROCHLORIDE |
ABHAI INC |
Labeling |
Approval |
05/08/2023 |
METOPROLOL SUCCINATE ANDA #210597 |
SUPPL-1 |
METOPROLOL SUCCINATE |
PRINSTON INC |
Labeling |
Approval |
05/08/2023 |
CEFAZOLIN SODIUM NDA #211413 |
ORIG-1 |
CEFAZOLIN SODIUM |
HQ SPCLT PHARMA |
Type 5 - New Formulation or New Manufacturer |
Approval |
05/08/2023 |
ROCURONIUM BROMIDE ANDA #213453 |
ORIG-1 |
ROCURONIUM BROMIDE |
MEITHEAL |
|
Approval |
05/08/2023 |
ALBUTEROL SULFATE ANDA #214531 |
SUPPL-1 |
ALBUTEROL SULFATE |
RITEDOSE CORP |
Labeling |
Approval |
05/08/2023 |
IVERMECTIN ANDA #215210 |
SUPPL-1 |
IVERMECTIN |
ZYDUS LIFESCIENCES |
Labeling |
Approval |
05/08/2023 |
BYLVAY NDA #215498 |
SUPPL-4 |
ODEVIXIBAT |
IPSEN |
Labeling |
Approval |
05/08/2023 |
PHENOXYBENZAMINE HYDROCHLORIDE ANDA #215600 |
ORIG-1 |
PHENOXYBENZAMINE HYDROCHLORIDE |
AUROBINDO PHARMA |
|
Approval |
05/08/2023 |
PHENOXYBENZAMINE HYDROCHLORIDE ANDA #215600 |
SUPPL-1 |
PHENOXYBENZAMINE HYDROCHLORIDE |
AUROBINDO PHARMA |
|
Approval |
05/08/2023 |
TIMOLOL MALEATE ANDA #217195 |
ORIG-1 |
TIMOLOL MALEATE |
SENTISS PHARMA |
|
Approval |
05/09/2023 |
ELELYSO BLA #022458 |
SUPPL-30 |
TALIGLUCERASE ALFA |
PFIZER |
|
Approval |
05/09/2023 |
QSYMIA NDA #022580 |
SUPPL-22 |
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE |
VIVUS |
REMS |
Approval |
05/09/2023 |
CLINDAMYCIN HYDROCHLORIDE ANDA #065442 |
SUPPL-19 |
CLINDAMYCIN HYDROCHLORIDE |
AUROBINDO PHARMA |
Labeling |
Approval |
05/09/2023 |
METOPROLOL SUCCINATE ANDA #090617 |
SUPPL-14 |
METOPROLOL SUCCINATE |
DR REDDYS LABS LTD |
Labeling |
Approval |
05/09/2023 |
METOPROLOL SUCCINATE ANDA #090617 |
SUPPL-17 |
METOPROLOL SUCCINATE |
DR REDDYS LABS LTD |
Labeling |
Approval |
05/09/2023 |
MYCOPHENOLIC SODIUM ANDA #208315 |
SUPPL-2 |
MYCOPHENOLIC SODIUM |
ALKEM LABS LTD |
Labeling |
Approval |
05/09/2023 |
ANGIOMAX RTU NDA #211215 |
SUPPL-2 |
BIVALIRUDIN |
MAIA PHARMS INC |
Labeling |
Approval |
05/09/2023 |
ZOLPIDEM TARTRATE NDA #215721 |
ORIG-1 |
ZOLPIDEM TARTRATE |
ALMATICA |
Type 3 - New Dosage Form |
Approval |
05/09/2023 |
RIBOCICLIB ANDA #215976 |
ORIG-1 |
RIBOCICLIB |
MSN LABS PVT LTD |
|
Tentative Approval |
05/09/2023 |
ACETAZOLAMIDE ANDA #217197 |
ORIG-1 |
ACETAZOLAMIDE |
NE RX PHARMA |
|
Approval |
05/09/2023 |
DEXAMETHASONE ANDA #217696 |
ORIG-1 |
DEXAMETHASONE |
NOVITIUM PHARMA |
|
Approval |
05/09/2023 |
ELFABRIO BLA #761161 |
ORIG-1 |
PEGUNIGALSIDASE ALFA-IWXJ |
CHIESI FARMACEUTICI SPA |
|
Approval |
05/10/2023 |
FUROSEMIDE NDA #018267 |
SUPPL-27 |
FUROSEMIDE |
HIKMA |
Manufacturing (CMC) |
Approval |
05/10/2023 |
FOSRENOL NDA #021468 |
SUPPL-26 |
LANTHANUM CARBONATE |
TAKEDA PHARMS USA |
Labeling |
Approval |
05/10/2023 |
PRAMIPEXOLE DIHYDROCHLORIDE ANDA #090781 |
SUPPL-9 |
PRAMIPEXOLE DIHYDROCHLORIDE |
GLENMARK PHARMS LTD |
Labeling |
Approval |
05/10/2023 |
PRAMIPEXOLE DIHYDROCHLORIDE ANDA #090781 |
SUPPL-10 |
PRAMIPEXOLE DIHYDROCHLORIDE |
GLENMARK PHARMS LTD |
Labeling |
Approval |
05/10/2023 |
MONTELUKAST SODIUM ANDA #090926 |
SUPPL-12 |
MONTELUKAST SODIUM |
GLENMARK PHARMS LTD |
Labeling |
Approval |
05/10/2023 |
MONTELUKAST SODIUM ANDA #090926 |
SUPPL-13 |
MONTELUKAST SODIUM |
GLENMARK PHARMS LTD |
Labeling |
Approval |
05/10/2023 |
DICLOFENAC SODIUM ANDA #204306 |
SUPPL-6 |
DICLOFENAC SODIUM |
AUROLIFE PHARMA LLC |
Manufacturing (CMC) |
Approval |
05/10/2023 |
FOSRENOL NDA #204734 |
SUPPL-8 |
LANTHANUM CARBONATE |
TAKEDA PHARMS USA |
Labeling |
Approval |
05/10/2023 |
REXULTI NDA #205422 |
SUPPL-9 |
BREXPIPRAZOLE |
OTSUKA |
Efficacy |
Approval |
05/10/2023 |
PROPYLTHIOURACIL ANDA #208867 |
ORIG-1 |
PROPYLTHIOURACIL |
MACLEODS PHARMS LTD |
|
Approval |
05/10/2023 |
LINAGLIPTIN;METFORMIN HYDROCHLORIDE ANDA #211921 |
ORIG-1 |
LINAGLIPTIN;METFORMIN HYDROCHLORIDE |
SUN PHARM INDS LTD |
|
Tentative Approval |
05/10/2023 |
VERQUVO NDA #214377 |
SUPPL-2 |
VERICIGUAT |
MERCK SHARP DOHME |
Labeling |
Approval |
05/10/2023 |
METHYLPREDNISOLONE ACETATE ANDA #214870 |
SUPPL-1 |
METHYLPREDNISOLONE ACETATE |
SLAYBACK PHARMA LLC |
Manufacturing (CMC) |
Approval |
05/10/2023 |
KETOROLAC TROMETHAMINE ANDA #217789 |
ORIG-1 |
KETOROLAC TROMETHAMINE |
CAPLIN |
|
Approval |
05/11/2023 |
CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER NDA #021117 |
SUPPL-25 |
CALCIUM CHLORIDE |
HOSPIRA |
Labeling |
Approval |
05/11/2023 |
CALDOLOR NDA #022348 |
SUPPL-24 |
IBUPROFEN |
CUMBERLAND PHARMS |
Efficacy |
Approval |
05/11/2023 |
CLINDAMYCIN PHOSPHATE ANDA #064050 |
SUPPL-22 |
CLINDAMYCIN PHOSPHATE |
PADAGIS US |
Labeling |
Approval |
05/11/2023 |
IBUPROFEN ANDA #072096 |
SUPPL-103 |
IBUPROFEN |
PERRIGO |
Labeling |
Approval |
05/11/2023 |
IBUPROFEN ANDA #072096 |
SUPPL-111 |
IBUPROFEN |
PERRIGO |
Manufacturing (CMC) |
Approval |
05/11/2023 |
IBUPROFEN ANDA #072096 |
SUPPL-115 |
IBUPROFEN |
PERRIGO |
Labeling |
Approval |
05/11/2023 |
VALACYCLOVIR HYDROCHLORIDE ANDA #078518 |
SUPPL-6 |
VALACYCLOVIR HYDROCHLORIDE |
MYLAN PHARMS INC |
Labeling |
Approval |
05/11/2023 |
QUETIAPINE FUMARATE ANDA #091388 |
SUPPL-13 |
QUETIAPINE FUMARATE |
AUROBINDO PHARMA LTD |
Labeling |
Approval |
05/11/2023 |
QUETIAPINE FUMARATE ANDA #091388 |
SUPPL-15 |
QUETIAPINE FUMARATE |
AUROBINDO PHARMA LTD |
Labeling |
Approval |
05/11/2023 |
QUETIAPINE FUMARATE ANDA #091388 |
SUPPL-16 |
QUETIAPINE FUMARATE |
AUROBINDO PHARMA LTD |
Labeling |
Approval |
05/11/2023 |
QUETIAPINE FUMARATE ANDA #091388 |
SUPPL-19 |
QUETIAPINE FUMARATE |
AUROBINDO PHARMA LTD |
Labeling |
Approval |
05/11/2023 |
QUETIAPINE FUMARATE ANDA #091388 |
SUPPL-20 |
QUETIAPINE FUMARATE |
AUROBINDO PHARMA LTD |
Labeling |
Approval |
05/11/2023 |
QUETIAPINE FUMARATE ANDA #091388 |
SUPPL-22 |
QUETIAPINE FUMARATE |
AUROBINDO PHARMA LTD |
Labeling |
Approval |
05/11/2023 |
COSENTYX BLA #125504 |
SUPPL-44 |
SECUKINUMAB |
NOVARTIS PHARMS CORP |
|
Approval |
05/11/2023 |
QUETIAPINE FUMARATE ANDA #201109 |
SUPPL-14 |
QUETIAPINE FUMARATE |
LUPIN LTD |
Labeling |
Approval |
05/11/2023 |
QUETIAPINE FUMARATE ANDA #201109 |
SUPPL-15 |
QUETIAPINE FUMARATE |
LUPIN LTD |
Labeling |
Approval |
05/11/2023 |
QUETIAPINE FUMARATE ANDA #201109 |
SUPPL-16 |
QUETIAPINE FUMARATE |
LUPIN LTD |
Labeling |
Approval |
05/11/2023 |
QUETIAPINE FUMARATE ANDA #201109 |
SUPPL-18 |
QUETIAPINE FUMARATE |
LUPIN LTD |
Labeling |
Approval |
05/11/2023 |
QUETIAPINE FUMARATE ANDA #201109 |
SUPPL-20 |
QUETIAPINE FUMARATE |
LUPIN LTD |
Labeling |
Approval |
05/11/2023 |
QUETIAPINE FUMARATE ANDA #201109 |
SUPPL-23 |
QUETIAPINE FUMARATE |
LUPIN LTD |
Labeling |
Approval |
05/11/2023 |
QUETIAPINE FUMARATE ANDA #201109 |
SUPPL-26 |
QUETIAPINE FUMARATE |
LUPIN LTD |
Labeling |
Approval |
05/11/2023 |
QUETIAPINE FUMARATE ANDA #201190 |
SUPPL-10 |
QUETIAPINE FUMARATE |
SUN PHARM |
Labeling |
Approval |
05/11/2023 |
QUETIAPINE FUMARATE ANDA #201190 |
SUPPL-12 |
QUETIAPINE FUMARATE |
SUN PHARM |
Labeling |
Approval |
05/11/2023 |
QUETIAPINE FUMARATE ANDA #201190 |
SUPPL-14 |
QUETIAPINE FUMARATE |
SUN PHARM |
Labeling |
Approval |
05/11/2023 |
QUETIAPINE FUMARATE ANDA #201190 |
SUPPL-16 |
QUETIAPINE FUMARATE |
SUN PHARM |
Labeling |
Approval |
05/11/2023 |
QUETIAPINE FUMARATE ANDA #201190 |
SUPPL-20 |
QUETIAPINE FUMARATE |
SUN PHARM |
Labeling |
Approval |
05/11/2023 |
QUETIAPINE FUMARATE ANDA #201504 |
SUPPL-9 |
QUETIAPINE FUMARATE |
ALKEM LABS LTD |
Labeling |
Approval |
05/11/2023 |
QUETIAPINE FUMARATE ANDA #201504 |
SUPPL-16 |
QUETIAPINE FUMARATE |
ALKEM LABS LTD |
Labeling |
Approval |
05/11/2023 |
QUETIAPINE FUMARATE ANDA #201504 |
SUPPL-17 |
QUETIAPINE FUMARATE |
ALKEM LABS LTD |
Labeling |
Approval |
05/11/2023 |
QUETIAPINE FUMARATE ANDA #201504 |
SUPPL-21 |
QUETIAPINE FUMARATE |
ALKEM LABS LTD |
Labeling |
Approval |
05/11/2023 |
QUETIAPINE FUMARATE ANDA #201504 |
SUPPL-23 |
QUETIAPINE FUMARATE |
ALKEM LABS LTD |
Labeling |
Approval |
05/11/2023 |
QUETIAPINE FUMARATE ANDA #201504 |
SUPPL-27 |
QUETIAPINE FUMARATE |
ALKEM LABS LTD |
Labeling |
Approval |
05/11/2023 |
QUETIAPINE FUMARATE ANDA #201504 |
SUPPL-28 |
QUETIAPINE FUMARATE |
ALKEM LABS LTD |
Labeling |
Approval |
05/11/2023 |
DOCETAXEL ANDA #203892 |
ORIG-1 |
DOCETAXEL |
MYLAN LABS LTD |
|
Approval |
05/11/2023 |
QUETIAPINE FUMARATE ANDA #206954 |
SUPPL-2 |
QUETIAPINE FUMARATE |
PRINSTON INC |
Labeling |
Approval |
05/11/2023 |
QUETIAPINE FUMARATE ANDA #209635 |
SUPPL-13 |
QUETIAPINE FUMARATE |
SCIEGEN PHARMS INC |
Labeling |
Approval |
05/11/2023 |
LENALIDOMIDE ANDA #212414 |
ORIG-1 |
LENALIDOMIDE |
HETERO LABS LTD V |
|
Approval |
05/11/2023 |
NITROFURANTOIN ANDA #212607 |
ORIG-1 |
NITROFURANTOIN |
AUROBINDO PHARMA |
|
Approval |
05/11/2023 |
THEOPHYLLINE ANDA #214113 |
ORIG-1 |
THEOPHYLLINE |
RHODES PHARMS |
|
Approval |
05/11/2023 |
ALENDRONATE SODIUM ANDA #214512 |
ORIG-1 |
ALENDRONATE SODIUM |
NOVITIUM PHARMA |
|
Approval |
05/11/2023 |
CARMUSTINE ANDA #214814 |
ORIG-1 |
CARMUSTINE |
MSN |
|
Approval |
05/11/2023 |
PACLITAXEL NDA #216338 |
ORIG-1 |
PACLITAXEL |
TEVA PHARMS INC |
Type 5 - New Formulation or New Manufacturer |
Approval |
05/11/2023 |
DICLOFENAC SODIUM ANDA #216548 |
ORIG-1 |
DICLOFENAC SODIUM |
RUBICON |
|
Approval |
05/12/2023 |
CARAFATE NDA #019183 |
SUPPL-21 |
SUCRALFATE |
ABBVIE |
Labeling |
Approval |
05/12/2023 |
LEXAPRO NDA #021323 |
SUPPL-55 |
ESCITALOPRAM OXALATE |
ABBVIE |
Efficacy |
Approval |
05/12/2023 |
LEXAPRO NDA #021365 |
SUPPL-39 |
ESCITALOPRAM OXALATE |
ABBVIE |
Efficacy |
Approval |
05/12/2023 |
LITHIUM CARBONATE ANDA #076795 |
SUPPL-15 |
LITHIUM CARBONATE |
APOTEX INC |
Labeling |
Approval |
05/12/2023 |
RISPERIDONE ANDA #079059 |
SUPPL-2 |
RISPERIDONE |
TRIS PHARMA INC |
Labeling |
Approval |
05/12/2023 |
RISPERIDONE ANDA #079059 |
SUPPL-3 |
RISPERIDONE |
TRIS PHARMA INC |
Labeling |
Approval |
05/12/2023 |
RISPERIDONE ANDA #079059 |
SUPPL-6 |
RISPERIDONE |
TRIS PHARMA INC |
Labeling |
Approval |
05/12/2023 |
RISPERIDONE ANDA #079059 |
SUPPL-7 |
RISPERIDONE |
TRIS PHARMA INC |
Labeling |
Approval |
05/12/2023 |
RISPERIDONE ANDA #079059 |
SUPPL-8 |
RISPERIDONE |
TRIS PHARMA INC |
Labeling |
Approval |
05/12/2023 |
RISPERIDONE ANDA #079059 |
SUPPL-11 |
RISPERIDONE |
TRIS PHARMA INC |
Labeling |
Approval |
05/12/2023 |
RISPERIDONE ANDA #079059 |
SUPPL-15 |
RISPERIDONE |
TRIS PHARMA INC |
Labeling |
Approval |
05/12/2023 |
RISEDRONATE SODIUM ANDA #090877 |
SUPPL-7 |
RISEDRONATE SODIUM |
APOTEX |
Labeling |
Approval |
05/12/2023 |
VENLAFAXINE HYDROCHLORIDE ANDA #203332 |
SUPPL-6 |
VENLAFAXINE HYDROCHLORIDE |
INVENTIA HLTHCARE |
Labeling |
Approval |
05/12/2023 |
VENLAFAXINE HYDROCHLORIDE ANDA #203332 |
SUPPL-7 |
VENLAFAXINE HYDROCHLORIDE |
INVENTIA HLTHCARE |
Labeling |
Approval |
05/12/2023 |
VENLAFAXINE HYDROCHLORIDE ANDA #203332 |
SUPPL-9 |
VENLAFAXINE HYDROCHLORIDE |
INVENTIA HLTHCARE |
Labeling |
Approval |
05/12/2023 |
AMMONIA N 13 ANDA #203543 |
SUPPL-2 |
AMMONIA N-13 |
SOFIE |
Manufacturing (CMC) |
Approval |
05/12/2023 |
BREO ELLIPTA NDA #204275 |
SUPPL-22 |
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE |
GLAXO GRP LTD |
Efficacy |
Approval |
05/12/2023 |
EPINEPHRINE NDA #205029 |
SUPPL-10 |
EPINEPHRINE |
BPI LABS |
Manufacturing (CMC) |
Approval |
05/12/2023 |
EVOTAZ NDA #206353 |
SUPPL-8 |
ATAZANAVIR SULFATE; COBICISTAT |
BRISTOL |
Labeling |
Approval |
05/12/2023 |
ATORVASTATIN CALCIUM ANDA #206536 |
SUPPL-16 |
ATORVASTATIN CALCIUM |
ZYDUS PHARMS |
Labeling |
Approval |
05/12/2023 |
CLOBAZAM ANDA #209796 |
SUPPL-2 |
CLOBAZAM |
HETERO LABS LTD III |
Labeling |
Approval |
05/12/2023 |
ABACAVIR;DOLUTEGRAVIR;LAMIVUDINE ANDA #210642 |
ORIG-1 |
ABACAVIR;DOLUTEGRAVIR;LAMIVUDINE |
AUROBINDO PHARMA LTD |
|
Tentative Approval |
05/12/2023 |
VEOZAH NDA #216578 |
ORIG-1 |
FEZOLINETANT |
ASTELLAS |
Type 1 - New Molecular Entity |
Approval |
05/12/2023 |
MESALAMINE ANDA #217337 |
ORIG-1 |
MESALAMINE |
SINOTHERAPEUTICS INC |
|
Approval |
05/12/2023 |
GABAPENTIN ANDA #217546 |
ORIG-1 |
GABAPENTIN |
LAURUS |
|
Approval |
05/12/2023 |
TECENTRIQ BLA #761034 |
SUPPL-49 |
ATEZOLIZUMAB |
GENENTECH INC |
|
Approval |
05/12/2023 |
TECENTRIQ BLA #761034 |
SUPPL-51 |
ATEZOLIZUMAB |
GENENTECH INC |
|
Approval |
05/15/2023 |
EXCEDRIN (MIGRAINE RELIEF) NDA #020802 |
SUPPL-42 |
ACETAMINOPHEN; ASPIRIN; CAFFEINE |
HALEON US HOLDINGS |
Manufacturing (CMC) |
Approval |
05/15/2023 |
DOCETAXEL NDA #022234 |
SUPPL-22 |
DOCETAXEL |
HOSPIRA INC |
Labeling |
Approval |
05/15/2023 |
ONDANSETRON HYDROCHLORIDE ANDA #077545 |
SUPPL-13 |
ONDANSETRON HYDROCHLORIDE |
HIKMA INTL PHARMS |
Labeling |
Approval |
05/15/2023 |
ONDANSETRON HYDROCHLORIDE ANDA #077545 |
SUPPL-14 |
ONDANSETRON HYDROCHLORIDE |
HIKMA INTL PHARMS |
Labeling |
Approval |
05/15/2023 |
IRINOTECAN HYDROCHLORIDE ANDA #077915 |
SUPPL-13 |
IRINOTECAN HYDROCHLORIDE |
HOSPIRA |
Labeling |
Approval |
05/15/2023 |
IRINOTECAN HYDROCHLORIDE ANDA #077915 |
SUPPL-14 |
IRINOTECAN HYDROCHLORIDE |
HOSPIRA |
Labeling |
Approval |
05/15/2023 |
POTASSIUM CHLORIDE 0.149% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER ANDA #078446 |
SUPPL-8 |
POTASSIUM CHLORIDE; SODIUM CHLORIDE |
ICU MEDICAL INC |
Labeling |
Approval |
05/15/2023 |
OMEPRAZOLE AND SODIUM BICARBONATE ANDA #203290 |
SUPPL-1 |
OMEPRAZOLE; SODIUM BICARBONATE |
ZYDUS PHARMS |
Labeling |
Approval |
05/15/2023 |
OMEPRAZOLE AND SODIUM BICARBONATE ANDA #203290 |
SUPPL-3 |
OMEPRAZOLE; SODIUM BICARBONATE |
ZYDUS PHARMS |
Labeling |
Approval |
05/15/2023 |
OMEPRAZOLE AND SODIUM BICARBONATE ANDA #203290 |
SUPPL-4 |
OMEPRAZOLE; SODIUM BICARBONATE |
ZYDUS PHARMS |
Labeling |
Approval |
05/15/2023 |
METHENAMINE HIPPURATE ANDA #205661 |
SUPPL-1 |
METHENAMINE HIPPURATE |
AUROBINDO PHARMA LTD |
Labeling |
Approval |
05/15/2023 |
METHENAMINE HIPPURATE ANDA #205661 |
SUPPL-3 |
METHENAMINE HIPPURATE |
AUROBINDO PHARMA LTD |
Labeling |
Approval |
05/15/2023 |
FULVESTRANT ANDA #205871 |
SUPPL-6 |
FULVESTRANT |
SAGENT PHARMS INC |
Labeling |
Approval |
05/15/2023 |
FULVESTRANT ANDA #205871 |
SUPPL-9 |
FULVESTRANT |
SAGENT PHARMS INC |
Labeling |
Approval |
05/15/2023 |
FULVESTRANT ANDA #205871 |
SUPPL-10 |
FULVESTRANT |
SAGENT PHARMS INC |
Labeling |
Approval |
05/15/2023 |
MELPHALAN HYDROCHLORIDE ANDA #206018 |
SUPPL-2 |
MELPHALAN HYDROCHLORIDE |
ACTAVIS LLC |
Labeling |
Approval |
05/15/2023 |
FIRDAPSE NDA #208078 |
SUPPL-9 |
AMIFAMPRIDINE PHOSPHATE |
CATALYST PHARMS |
Labeling |
Approval |
05/15/2023 |
TERIFLUNOMIDE ANDA #209555 |
ORIG-1 |
TERIFLUNOMIDE |
NATCO |
|
Approval |
05/15/2023 |
VIVIMUSTA NDA #212209 |
SUPPL-3 |
BENDAMUSTINE HYDROCHLORIDE |
SLAYBACK PHARMA LLC |
Labeling |
Approval |
05/15/2023 |
NALOXONE HYDROCHLORIDE ANDA #212300 |
SUPPL-3 |
NALOXONE HYDROCHLORIDE |
HIKMA |
Labeling |
Approval |
05/15/2023 |
INREBIC NDA #212327 |
SUPPL-5 |
FEDRATINIB HYDROCHLORIDE |
BRISTOL-MYERS |
Labeling |
Approval |
05/15/2023 |
ESOMEPRAZOLE MAGNESIUM ANDA #216349 |
SUPPL-2 |
ESOMEPRAZOLE MAGNESIUM |
GRAVITI PHARMS |
Labeling |
Approval |
05/15/2023 |
FAMOTIDINE ANDA #216400 |
ORIG-1 |
FAMOTIDINE |
ALKEM LABS LTD |
|
Approval |
05/15/2023 |
DEXMEDETOMIDINE HYDROCHLORIDE ANDA #216604 |
ORIG-1 |
DEXMEDETOMIDINE HYDROCHLORIDE |
AMNEAL |
|
Approval |
05/15/2023 |
NALOXONE HYDROCHLORIDE ANDA #216624 |
SUPPL-1 |
NALOXONE HYDROCHLORIDE |
ACCORD HLTHCARE |
Labeling |
Approval |
05/15/2023 |
RUFINAMIDE ANDA #216688 |
ORIG-1 |
RUFINAMIDE |
MICRO LABS |
|
Approval |
05/16/2023 |
NALOXONE HYDROCHLORIDE ANDA #072076 |
SUPPL-22 |
NALOXONE HYDROCHLORIDE |
INTL MEDICATION |
Labeling |
Approval |
05/16/2023 |
NALOXONE HYDROCHLORIDE ANDA #072076 |
SUPPL-24 |
NALOXONE HYDROCHLORIDE |
INTL MEDICATION |
Labeling |
Approval |
05/16/2023 |
AMINOPHYLLINE ANDA #087600 |
SUPPL-28 |
AMINOPHYLLINE |
AM REGENT |
Manufacturing (CMC) |
Approval |
05/16/2023 |
DAPTOMYCIN ANDA #206077 |
SUPPL-4 |
DAPTOMYCIN |
FRESENIUS KABI USA |
Labeling |
Approval |
05/16/2023 |
DAPTOMYCIN ANDA #206077 |
SUPPL-6 |
DAPTOMYCIN |
FRESENIUS KABI USA |
Labeling |
Approval |
05/16/2023 |
DAPTOMYCIN ANDA #206077 |
SUPPL-9 |
DAPTOMYCIN |
FRESENIUS KABI USA |
Labeling |
Approval |
05/16/2023 |
FOSAPREPITANT DIMEGLUMINE ANDA #214683 |
ORIG-1 |
FOSAPREPITANT DIMEGLUMINE |
PIRAMAL CRITICAL |
|
Approval |
05/16/2023 |
FENOPROFEN CALCIUM ANDA #215548 |
ORIG-1 |
FENOPROFEN CALCIUM |
MISEMER |
|
Approval |
05/16/2023 |
NALOXONE HYDROCHLORIDE ANDA #215964 |
SUPPL-1 |
NALOXONE HYDROCHLORIDE |
PAR STERILE PRODUCTS |
Labeling |
Approval |
05/16/2023 |
METHYLNALTREXONE BROMIDE ANDA #216965 |
ORIG-1 |
METHYLNALTREXONE BROMIDE |
GLAND PHARMA LTD |
|
Tentative Approval |
05/16/2023 |
EPHEDRINE SULFATE ANDA #217276 |
ORIG-1 |
EPHEDRINE SULFATE |
ZYDUS PHARMS |
|
Approval |
05/17/2023 |
INTRALIPID 10% NDA #017643 |
SUPPL-83 |
SOYBEAN OIL |
FRESENIUS |
Labeling |
Approval |
05/17/2023 |
INTRALIPID 20% NDA #018449 |
SUPPL-50 |
SOYBEAN OIL |
FRESENIUS |
Labeling |
Approval |
05/17/2023 |
INTRALIPID 20% NDA #018449 |
SUPPL-51 |
SOYBEAN OIL |
FRESENIUS |
Labeling |
Approval |
05/17/2023 |
NUTRILIPID 10% NDA #019531 |
SUPPL-13 |
SOYBEAN OIL |
B BRAUN |
Manufacturing (CMC) |
Approval |
05/17/2023 |
NUTRILIPID 10% NDA #019531 |
SUPPL-16 |
SOYBEAN OIL |
B BRAUN |
Labeling |
Approval |
05/17/2023 |
NUTRILIPID 20% NDA #019531 |
SUPPL-13 |
SOYBEAN OIL |
B BRAUN |
Manufacturing (CMC) |
Approval |
05/17/2023 |
NUTRILIPID 20% NDA #019531 |
SUPPL-16 |
SOYBEAN OIL |
B BRAUN |
Labeling |
Approval |
05/17/2023 |
INTRALIPID 30% NDA #019942 |
SUPPL-21 |
SOYBEAN OIL |
FRESENIUS |
Labeling |
Approval |
05/17/2023 |
INTRALIPID 20% NDA #020248 |
SUPPL-27 |
SOYBEAN OIL |
FRESENIUS |
Labeling |
Approval |
05/17/2023 |
INTRALIPID 20% NDA #020248 |
SUPPL-28 |
SOYBEAN OIL |
FRESENIUS |
Labeling |
Approval |
05/17/2023 |
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE ANDA #089534 |
SUPPL-49 |
HYDROCHLOROTHIAZIDE; SPIRONOLACTONE |
SUN PHARM INDUSTRIES |
Labeling |
Approval |
05/17/2023 |
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE ANDA #089534 |
SUPPL-50 |
HYDROCHLOROTHIAZIDE; SPIRONOLACTONE |
SUN PHARM INDUSTRIES |
Labeling |
Approval |
05/17/2023 |
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE ANDA #089534 |
SUPPL-55 |
HYDROCHLOROTHIAZIDE; SPIRONOLACTONE |
SUN PHARM INDUSTRIES |
Labeling |
Approval |
05/17/2023 |
LEVETIRACETAM ANDA #090876 |
SUPPL-3 |
LEVETIRACETAM |
FRESENIUS KABI USA |
Labeling |
Approval |
05/17/2023 |
LEVETIRACETAM ANDA #090876 |
SUPPL-4 |
LEVETIRACETAM |
FRESENIUS KABI USA |
Labeling |
Approval |
05/17/2023 |
KABIVEN IN PLASTIC CONTAINER NDA #200656 |
SUPPL-18 |
AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM GLYCEROPHOSPHATE; SOYBEAN OIL |
FRESENIUS KABI USA |
Labeling |
Approval |
05/17/2023 |
PERIKABIVEN IN PLASTIC CONTAINER NDA #200656 |
SUPPL-18 |
AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM GLYCEROPHOSPHATE; SOYBEAN OIL |
FRESENIUS KABI USA |
Labeling |
Approval |
05/17/2023 |
CLINOLIPID 20% NDA #204508 |
SUPPL-19 |
OLIVE OIL; SOYBEAN OIL |
BAXTER HLTHCARE CORP |
Labeling |
Approval |
05/17/2023 |
CLINOLIPID 20% NDA #204508 |
SUPPL-21 |
OLIVE OIL; SOYBEAN OIL |
BAXTER HLTHCARE CORP |
Labeling |
Approval |
05/17/2023 |
BRIVIACT NDA #205836 |
SUPPL-14 |
BRIVARACETAM |
UCB INC |
Labeling |
Approval |
05/17/2023 |
BRIVIACT NDA #205837 |
SUPPL-11 |
BRIVARACETAM |
UCB INC |
Labeling |
Approval |
05/17/2023 |
BRIVIACT NDA #205838 |
SUPPL-11 |
BRIVARACETAM |
UCB INC |
Labeling |
Approval |
05/17/2023 |
SMOFLIPID 20% NDA #207648 |
SUPPL-10 |
FISH OIL; MEDIUM CHAIN TRIGLYCERIDES; OLIVE OIL; SOYBEAN OIL |
FRESENIUS KABI USA |
Labeling |
Approval |
05/17/2023 |
ISOSULFAN BLUE ANDA #210294 |
ORIG-1 |
ISOSULFAN BLUE |
AM REGENT |
|
Approval |
05/17/2023 |
OMEGAVEN NDA #210589 |
SUPPL-3 |
FISH OIL TRIGLYCERIDES |
FRESENIUS KABI USA |
Labeling |
Approval |
05/18/2023 |
FEMHRT NDA #021065 |
SUPPL-25 |
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE |
APIL |
Labeling |
Approval |
05/18/2023 |
FEMHRT NDA #021065 |
SUPPL-26 |
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE |
APIL |
Labeling |
Approval |
05/18/2023 |
CLARITHROMYCIN ANDA #065136 |
SUPPL-20 |
CLARITHROMYCIN |
SANDOZ |
Labeling |
Approval |
05/18/2023 |
CLARITHROMYCIN ANDA #065136 |
SUPPL-22 |
CLARITHROMYCIN |
SANDOZ |
Labeling |
Approval |
05/18/2023 |
CLARITHROMYCIN ANDA #065136 |
SUPPL-25 |
CLARITHROMYCIN |
SANDOZ |
Labeling |
Approval |
05/18/2023 |
CLARITHROMYCIN ANDA #065136 |
SUPPL-27 |
CLARITHROMYCIN |
SANDOZ |
Labeling |
Approval |
05/18/2023 |
CLARITHROMYCIN ANDA #065136 |
SUPPL-29 |
CLARITHROMYCIN |
SANDOZ |
Labeling |
Approval |
05/18/2023 |
CLARITHROMYCIN ANDA #065144 |
SUPPL-19 |
CLARITHROMYCIN |
SANDOZ |
Labeling |
Approval |
05/18/2023 |
CLARITHROMYCIN ANDA #065144 |
SUPPL-21 |
CLARITHROMYCIN |
SANDOZ |
Labeling |
Approval |
05/18/2023 |
CLARITHROMYCIN ANDA #065144 |
SUPPL-24 |
CLARITHROMYCIN |
SANDOZ |
Labeling |
Approval |
05/18/2023 |
CLARITHROMYCIN ANDA #065144 |
SUPPL-26 |
CLARITHROMYCIN |
SANDOZ |
Labeling |
Approval |
05/18/2023 |
CLARITHROMYCIN ANDA #065144 |
SUPPL-28 |
CLARITHROMYCIN |
SANDOZ |
Labeling |
Approval |
05/18/2023 |
NALOXONE HYDROCHLORIDE ANDA #070639 |
SUPPL-19 |
NALOXONE HYDROCHLORIDE |
INTL MEDICATION |
Labeling |
Approval |
05/18/2023 |
IMBRUVICA NDA #205552 |
SUPPL-40 |
IBRUTINIB |
PHARMACYCLICS LLC |
Efficacy |
Approval |
05/18/2023 |
IMBRUVICA NDA #210563 |
SUPPL-17 |
IBRUTINIB |
PHARMACYCLICS LLC |
Efficacy |
Approval |
05/18/2023 |
RINVOQ NDA #211675 |
SUPPL-15 |
UPADACITINIB |
ABBVIE |
Efficacy |
Approval |
05/18/2023 |
MIEBO NDA #216675 |
ORIG-1 |
PERFLUOROHEXYLOCTANE |
BAUSCH AND LOMB INC |
Type 1 - New Molecular Entity |
Approval |
05/18/2023 |
VENLAFAXINE HYDROCHLORIDE ANDA #217390 |
ORIG-1 |
VENLAFAXINE HYDROCHLORIDE |
GRANULES |
|
Approval |
05/18/2023 |
CYLTEZO BLA #761058 |
SUPPL-16 |
ADALIMUMAB-ADBM |
BOEHRINGER INGELHEIM |
|
Approval |
05/19/2023 |
CLOZARIL NDA #019758 |
SUPPL-103 |
CLOZAPINE |
HERITAGE LIFE |
Labeling |
Approval |
05/19/2023 |
YASMIN NDA #021098 |
SUPPL-29 |
DROSPIRENONE; ETHINYL ESTRADIOL |
BAYER HLTHCARE |
Labeling |
Approval |
05/19/2023 |
YAZ NDA #021676 |
SUPPL-20 |
DROSPIRENONE; ETHINYL ESTRADIOL |
BAYER HLTHCARE |
Labeling |
Approval |
05/19/2023 |
BEYAZ NDA #022532 |
SUPPL-10 |
DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM |
BAYER HLTHCARE |
Labeling |
Approval |
05/19/2023 |
SAFYRAL NDA #022574 |
SUPPL-10 |
DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM |
BAYER HLTHCARE |
Labeling |
Approval |
05/19/2023 |
LEVETIRACETAM ANDA #090263 |
SUPPL-11 |
LEVETIRACETAM |
CHARTWELL MOLECULAR |
Labeling |
Approval |
05/19/2023 |
LEVETIRACETAM ANDA #090263 |
SUPPL-12 |
LEVETIRACETAM |
CHARTWELL MOLECULAR |
Labeling |
Approval |
05/19/2023 |
LEVETIRACETAM ANDA #090263 |
SUPPL-13 |
LEVETIRACETAM |
CHARTWELL MOLECULAR |
Labeling |
Approval |
05/19/2023 |
LEVETIRACETAM ANDA #090263 |
SUPPL-14 |
LEVETIRACETAM |
CHARTWELL MOLECULAR |
Labeling |
Approval |
05/19/2023 |
LEVETIRACETAM ANDA #090263 |
SUPPL-15 |
LEVETIRACETAM |
CHARTWELL MOLECULAR |
Labeling |
Approval |
05/19/2023 |
LEVETIRACETAM ANDA #090992 |
SUPPL-5 |
LEVETIRACETAM |
AMNEAL PHARMS |
Labeling |
Approval |
05/19/2023 |
LEVETIRACETAM ANDA #090992 |
SUPPL-6 |
LEVETIRACETAM |
AMNEAL PHARMS |
Labeling |
Approval |
05/19/2023 |
LEVETIRACETAM ANDA #090992 |
SUPPL-7 |
LEVETIRACETAM |
AMNEAL PHARMS |
Labeling |
Approval |
05/19/2023 |
LEVETIRACETAM ANDA #090992 |
SUPPL-8 |
LEVETIRACETAM |
AMNEAL PHARMS |
Labeling |
Approval |
05/19/2023 |
LEVETIRACETAM ANDA #090992 |
SUPPL-9 |
LEVETIRACETAM |
AMNEAL PHARMS |
Labeling |
Approval |
05/19/2023 |
DICLOFENAC SODIUM AND MISOPROSTOL ANDA #200158 |
SUPPL-7 |
DICLOFENAC SODIUM; MISOPROSTOL |
SANDOZ |
Labeling |
Approval |
05/19/2023 |
DICLOFENAC SODIUM AND MISOPROSTOL ANDA #200158 |
SUPPL-8 |
DICLOFENAC SODIUM; MISOPROSTOL |
SANDOZ |
Labeling |
Approval |
05/19/2023 |
DICLOFENAC SODIUM AND MISOPROSTOL ANDA #200158 |
SUPPL-9 |
DICLOFENAC SODIUM; MISOPROSTOL |
SANDOZ |
Labeling |
Approval |
05/19/2023 |
DICLOFENAC SODIUM AND MISOPROSTOL ANDA #200158 |
SUPPL-10 |
DICLOFENAC SODIUM; MISOPROSTOL |
SANDOZ |
Labeling |
Approval |
05/19/2023 |
DICLOFENAC SODIUM AND MISOPROSTOL ANDA #200158 |
SUPPL-11 |
DICLOFENAC SODIUM; MISOPROSTOL |
SANDOZ |
Labeling |
Approval |
05/19/2023 |
DICLOFENAC SODIUM AND MISOPROSTOL ANDA #200158 |
SUPPL-12 |
DICLOFENAC SODIUM; MISOPROSTOL |
SANDOZ |
Labeling |
Approval |
05/19/2023 |
DICLOFENAC SODIUM AND MISOPROSTOL ANDA #200158 |
SUPPL-13 |
DICLOFENAC SODIUM; MISOPROSTOL |
SANDOZ |
Labeling |
Approval |
05/19/2023 |
DICLOFENAC SODIUM AND MISOPROSTOL ANDA #200158 |
SUPPL-14 |
DICLOFENAC SODIUM; MISOPROSTOL |
SANDOZ |
Labeling |
Approval |
05/19/2023 |
LAMOTRIGINE ANDA #200672 |
SUPPL-12 |
LAMOTRIGINE |
ACTAVIS ELIZABETH |
Labeling |
Approval |
05/19/2023 |
LAMOTRIGINE ANDA #200672 |
SUPPL-13 |
LAMOTRIGINE |
ACTAVIS ELIZABETH |
Labeling |
Approval |
05/19/2023 |
ZOLEDRONIC ACID ANDA #202923 |
SUPPL-7 |
ZOLEDRONIC ACID |
USV |
Labeling |
Approval |
05/19/2023 |
ZOLEDRONIC ACID ANDA #202923 |
SUPPL-14 |
ZOLEDRONIC ACID |
USV |
Labeling |
Approval |
05/19/2023 |
MOXIFLOXACIN HYDROCHLORIDE IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER ANDA #205833 |
SUPPL-9 |
MOXIFLOXACIN HYDROCHLORIDE |
MYLAN LABS LTD |
Labeling |
Approval |
05/19/2023 |
DROSPIRENONE AND ETHINYL ESTRADIOL ANDA #205876 |
SUPPL-3 |
DROSPIRENONE; ETHINYL ESTRADIOL |
APOTEX |
Labeling |
Approval |
05/19/2023 |
DROSPIRENONE AND ETHINYL ESTRADIOL ANDA #205876 |
SUPPL-6 |
DROSPIRENONE; ETHINYL ESTRADIOL |
APOTEX |
Labeling |
Approval |
05/19/2023 |
TETRABENAZINE ANDA #206093 |
SUPPL-1 |
TETRABENAZINE |
APOTEX |
Labeling |
Approval |
05/19/2023 |
SEVELAMER CARBONATE ANDA #206094 |
SUPPL-3 |
SEVELAMER CARBONATE |
DR REDDYS |
Labeling |
Approval |
05/19/2023 |
SEVELAMER CARBONATE ANDA #206094 |
SUPPL-5 |
SEVELAMER CARBONATE |
DR REDDYS |
Labeling |
Approval |
05/19/2023 |
ALISKIREN HEMIFUMARATE ANDA #206665 |
SUPPL-2 |
ALISKIREN HEMIFUMARATE |
ANCHEN PHARMS |
Labeling |
Approval |
05/19/2023 |
ACETAZOLAMIDE ANDA #207401 |
SUPPL-1 |
ACETAZOLAMIDE |
MICRO LABS LTD INDIA |
Labeling |
Approval |
05/19/2023 |
ACETAZOLAMIDE ANDA #207659 |
SUPPL-3 |
ACETAZOLAMIDE |
ACCORD HLTHCARE |
Labeling |
Approval |
05/19/2023 |
DEFERASIROX ANDA #209433 |
SUPPL-1 |
DEFERASIROX |
ICHNOS |
Labeling |
Approval |
05/19/2023 |
DEFERASIROX ANDA #209433 |
SUPPL-2 |
DEFERASIROX |
ICHNOS |
Labeling |
Approval |
05/19/2023 |
COLCHICINE ANDA #210425 |
SUPPL-2 |
COLCHICINE |
GRANULES |
Labeling |
Approval |
05/19/2023 |
CARBOPROST TROMETHAMINE ANDA #216824 |
ORIG-1 |
CARBOPROST TROMETHAMINE |
SOLA PHARMS |
|
Approval |
05/19/2023 |
AMITRIPTYLINE HYDROCHLORIDE ANDA #217411 |
ORIG-1 |
AMITRIPTYLINE HYDROCHLORIDE |
RISING |
|
Approval |
05/19/2023 |
EPKINLY BLA #761324 |
ORIG-1 |
EPCORITAMAB-BYSP |
GENMAB US, INC. |
|
Approval |
05/22/2023 |
LEVETIRACETAM ANDA #201157 |
SUPPL-8 |
LEVETIRACETAM |
PHARM ASSOC |
Labeling |
Approval |
05/22/2023 |
HYDROMORPHONE HYDROCHLORIDE ANDA #204278 |
SUPPL-17 |
HYDROMORPHONE HYDROCHLORIDE |
PADAGIS US |
Labeling |
Approval |
05/22/2023 |
LEVETIRACETAM ANDA #204312 |
SUPPL-9 |
LEVETIRACETAM |
EUGIA PHARMA |
Labeling |
Approval |
05/22/2023 |
ITRACONAZOLE ANDA #206741 |
SUPPL-14 |
ITRACONAZOLE |
ALEMBIC |
Labeling |
Approval |
05/22/2023 |
RYDAPT NDA #207997 |
SUPPL-10 |
MIDOSTAURIN |
NOVARTIS |
Labeling |
Approval |
05/22/2023 |
ESOMEPRAZOLE MAGNESIUM ANDA #209647 |
SUPPL-4 |
ESOMEPRAZOLE MAGNESIUM |
AMNEAL PHARMS NY |
Labeling |
Approval |
05/22/2023 |
ESOMEPRAZOLE MAGNESIUM ANDA #209647 |
SUPPL-5 |
ESOMEPRAZOLE MAGNESIUM |
AMNEAL PHARMS NY |
Labeling |
Approval |
05/22/2023 |
ESOMEPRAZOLE MAGNESIUM ANDA #209647 |
SUPPL-7 |
ESOMEPRAZOLE MAGNESIUM |
AMNEAL PHARMS NY |
Labeling |
Approval |
05/22/2023 |
CLOBAZAM ANDA #209718 |
SUPPL-4 |
CLOBAZAM |
AMNEAL PHARMS CO |
Labeling |
Approval |
05/22/2023 |
CLOBAZAM ANDA #209718 |
SUPPL-9 |
CLOBAZAM |
AMNEAL PHARMS CO |
Labeling |
Approval |
05/22/2023 |
ESOMEPRAZOLE MAGNESIUM ANDA #209735 |
SUPPL-9 |
ESOMEPRAZOLE MAGNESIUM |
SUN PHARM |
Labeling |
Approval |
05/22/2023 |
ESOMEPRAZOLE MAGNESIUM ANDA #209735 |
SUPPL-11 |
ESOMEPRAZOLE MAGNESIUM |
SUN PHARM |
Labeling |
Approval |
05/22/2023 |
ESOMEPRAZOLE MAGNESIUM ANDA #209735 |
SUPPL-13 |
ESOMEPRAZOLE MAGNESIUM |
SUN PHARM |
Labeling |
Approval |
05/22/2023 |
ESOMEPRAZOLE MAGNESIUM ANDA #210559 |
SUPPL-3 |
ESOMEPRAZOLE MAGNESIUM |
INDCHEMIE HEALTH |
Labeling |
Approval |
05/22/2023 |
ESOMEPRAZOLE MAGNESIUM ANDA #210559 |
SUPPL-6 |
ESOMEPRAZOLE MAGNESIUM |
INDCHEMIE HEALTH |
Labeling |
Approval |
05/22/2023 |
CLOBAZAM ANDA #210746 |
SUPPL-7 |
CLOBAZAM |
VISTAPHARM |
Labeling |
Approval |
05/22/2023 |
CLOBAZAM ANDA #210978 |
SUPPL-6 |
CLOBAZAM |
TARO |
Labeling |
Approval |
05/22/2023 |
LEVETIRACETAM ANDA #211954 |
SUPPL-1 |
LEVETIRACETAM |
MICRO LABS |
Labeling |
Approval |
05/22/2023 |
LEVETIRACETAM ANDA #211954 |
SUPPL-2 |
LEVETIRACETAM |
MICRO LABS |
Labeling |
Approval |
05/22/2023 |
AYVAKIT NDA #212608 |
SUPPL-13 |
AVAPRITINIB |
BLUEPRINT MEDICINES |
Efficacy |
Approval |
05/22/2023 |
VIGPODER ANDA #214961 |
SUPPL-2 |
VIGABATRIN |
PYROS PHARMS |
Labeling |
Approval |
05/22/2023 |
PEMETREXED NDA #215179 |
ORIG-1 |
PEMETREXED DISODIUM |
SHILPA |
Type 5 - New Formulation or New Manufacturer |
Approval |
05/22/2023 |
LEVOLEUCOVORIN CALCIUM ANDA #217314 |
ORIG-1 |
LEVOLEUCOVORIN CALCIUM |
HAINAN POLY PHARM |
|
Approval |
05/22/2023 |
OPVEE NDA #217470 |
ORIG-1 |
NALMEFENE HYDROCHLORIDE |
INDIVIOR |
Type 3 - New Dosage Form |
Approval |
05/23/2023 |
CHORIONIC GONADOTROPIN BLA #017016 |
SUPPL-172 |
GONADOTROPIN, CHORIONIC |
FERRING |
|
Approval |
05/23/2023 |
DIVIGEL NDA #022038 |
SUPPL-10 |
ESTRADIOL |
VERTICAL PHARMS |
Labeling |
Approval |
05/23/2023 |
ROPIVACAINE HYDROCHLORIDE ANDA #090194 |
SUPPL-2 |
ROPIVACAINE HYDROCHLORIDE |
HOSPIRA |
Labeling |
Approval |
05/23/2023 |
ROPIVACAINE HYDROCHLORIDE ANDA #090194 |
SUPPL-5 |
ROPIVACAINE HYDROCHLORIDE |
HOSPIRA |
Labeling |
Approval |
05/23/2023 |
BACLOFEN ANDA #090334 |
SUPPL-3 |
BACLOFEN |
APPCO |
Labeling |
Approval |
05/23/2023 |
GABAPENTIN ANDA #090335 |
SUPPL-4 |
GABAPENTIN |
MYLAN PHARMS INC |
Labeling |
Approval |
05/23/2023 |
GABAPENTIN ANDA #090335 |
SUPPL-5 |
GABAPENTIN |
MYLAN PHARMS INC |
Labeling |
Approval |
05/23/2023 |
GABAPENTIN ANDA #090335 |
SUPPL-6 |
GABAPENTIN |
MYLAN PHARMS INC |
Labeling |
Approval |
05/23/2023 |
GABAPENTIN ANDA #090335 |
SUPPL-8 |
GABAPENTIN |
MYLAN PHARMS INC |
Labeling |
Approval |
05/23/2023 |
GABAPENTIN ANDA #090335 |
SUPPL-9 |
GABAPENTIN |
MYLAN PHARMS INC |
Labeling |
Approval |
05/23/2023 |
GABAPENTIN ANDA #090335 |
SUPPL-10 |
GABAPENTIN |
MYLAN PHARMS INC |
Labeling |
Approval |
05/23/2023 |
GABAPENTIN ANDA #090335 |
SUPPL-11 |
GABAPENTIN |
MYLAN PHARMS INC |
Labeling |
Approval |
05/23/2023 |
SIMVASTATIN ANDA #090383 |
SUPPL-12 |
SIMVASTATIN |
MICRO LABS |
Labeling |
Approval |
05/23/2023 |
SIMVASTATIN ANDA #090383 |
SUPPL-13 |
SIMVASTATIN |
MICRO LABS |
Labeling |
Approval |
05/23/2023 |
SIMVASTATIN ANDA #090383 |
SUPPL-14 |
SIMVASTATIN |
MICRO LABS |
Labeling |
Approval |
05/23/2023 |
SIMVASTATIN ANDA #090383 |
SUPPL-15 |
SIMVASTATIN |
MICRO LABS |
Labeling |
Approval |
05/23/2023 |
EXEMESTANE ANDA #200898 |
SUPPL-12 |
EXEMESTANE |
ALVOGEN |
Labeling |
Approval |
05/23/2023 |
ZOLMITRIPTAN ANDA #202279 |
SUPPL-5 |
ZOLMITRIPTAN |
JUBILANT GENERICS |
Labeling |
Approval |
05/23/2023 |
OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE ANDA #203580 |
SUPPL-18 |
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL |
TORRENT |
Labeling |
Approval |
05/23/2023 |
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE ANDA #205954 |
SUPPL-15 |
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE |
ALVOGEN |
Labeling |
Approval |
05/23/2023 |
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE ANDA #205954 |
SUPPL-21 |
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE |
ALVOGEN |
Labeling |
Approval |
05/23/2023 |
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE ANDA #205954 |
SUPPL-23 |
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE |
ALVOGEN |
Labeling |
Approval |
05/23/2023 |
LEVETIRACETAM IN SODIUM CHLORIDE ANDA #206880 |
SUPPL-7 |
LEVETIRACETAM |
GLAND PHARMA LTD |
Labeling |
Approval |
05/23/2023 |
LEVETIRACETAM IN SODIUM CHLORIDE ANDA #207160 |
SUPPL-5 |
LEVETIRACETAM |
EUGIA PHARMA |
Labeling |
Approval |
05/23/2023 |
BRIXADI NDA #210136 |
ORIG-1 |
BUPRENORPHINE |
BRAEBURN |
Type 3 - New Dosage Form |
Approval |
05/23/2023 |
FEXOFENADINE HYDROCHLORIDE ANDA #213466 |
ORIG-1 |
FEXOFENADINE HYDROCHLORIDE |
AUROBINDO PHARMA LTD |
|
Approval |
05/23/2023 |
METHYLPHENIDATE HYDROCHLORIDE ANDA #214447 |
ORIG-1 |
METHYLPHENIDATE HYDROCHLORIDE |
ALKEM LABS LTD |
|
Approval |
05/23/2023 |
HALOPERIDOL DECANOATE ANDA #216730 |
ORIG-1 |
HALOPERIDOL DECANOATE |
MANKIND PHARMA |
|
Approval |
05/23/2023 |
TOFACITINIB ANDA #216770 |
ORIG-1 |
TOFACITINIB |
TEVA PHARMS INC |
|
Tentative Approval |
05/23/2023 |
XACDURO (COPACKAGED) NDA #216974 |
ORIG-1 |
DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM |
ENTASIS THERAP |
Type 1 - New Molecular Entity and Type 4 - New Combination |
Approval |
05/23/2023 |
REGADENOSON ANDA #217455 |
ORIG-1 |
REGADENOSON |
BAXTER HLTHCARE CORP |
|
Approval |
05/23/2023 |
YUFLYMA BLA #761219 |
ORIG-1 |
ADALIMUMAB-AATY |
CELLTRION |
|
Approval |
05/24/2023 |
RISEDRONATE SODIUM ANDA #079215 |
SUPPL-4 |
RISEDRONATE SODIUM |
TEVA PHARMS USA |
Labeling |
Approval |
05/24/2023 |
IMIPRAMINE HYDROCHLORIDE ANDA #083745 |
SUPPL-123 |
IMIPRAMINE HYDROCHLORIDE |
SANDOZ |
Labeling |
Approval |
05/24/2023 |
IMIPRAMINE HYDROCHLORIDE ANDA #084936 |
SUPPL-109 |
IMIPRAMINE HYDROCHLORIDE |
SANDOZ |
Labeling |
Approval |
05/24/2023 |
IMIPRAMINE HYDROCHLORIDE ANDA #084937 |
SUPPL-129 |
IMIPRAMINE HYDROCHLORIDE |
SANDOZ |
Labeling |
Approval |
05/24/2023 |
NORETHINDRONE ANDA #091209 |
SUPPL-10 |
NORETHINDRONE |
GLENMARK PHARMS LTD |
Labeling |
Approval |
05/24/2023 |
LUMIZYME BLA #125291 |
SUPPL-159 |
ALGLUCOSIDASE ALFA |
GENZYME |
|
Approval |
05/24/2023 |
DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE ANDA #202934 |
SUPPL-1 |
DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE |
ACTAVIS ELIZABETH |
Labeling |
Approval |
05/24/2023 |
ACETAZOLAMIDE ANDA #205530 |
SUPPL-11 |
ACETAZOLAMIDE |
HERITAGE PHARMA |
Labeling |
Approval |
05/24/2023 |
OXYBUTYNIN CHLORIDE ANDA #206121 |
SUPPL-6 |
OXYBUTYNIN CHLORIDE |
UNIQUE |
Labeling |
Approval |
05/24/2023 |
ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE ANDA #206845 |
SUPPL-8 |
ONDANSETRON HYDROCHLORIDE |
ACCORD HLTHCARE |
Labeling |
Approval |
05/24/2023 |
ONDANSETRON HYDROCHLORIDE ANDA #206846 |
SUPPL-8 |
ONDANSETRON HYDROCHLORIDE |
ACCORD HLTHCARE |
Labeling |
Approval |
05/24/2023 |
READYPREP CHG NDA #207964 |
SUPPL-3 |
CHLORHEXIDINE GLUCONATE |
MEDLINE INDUSTRIES |
Manufacturing (CMC) |
Approval |
05/24/2023 |
METHIMAZOLE ANDA #209827 |
ORIG-1 |
METHIMAZOLE |
MACLEODS PHARMS LTD |
|
Approval |
05/24/2023 |
FINGOLIMOD HYDROCHLORIDE ANDA #210252 |
ORIG-1 |
FINGOLIMOD HYDROCHLORIDE |
BIONPHARMA |
|
Approval |
05/24/2023 |
VENLAFAXINE HYDROCHLORIDE ANDA #214419 |
SUPPL-1 |
VENLAFAXINE HYDROCHLORIDE |
ASCENT PHARMS INC |
Labeling |
Approval |
05/24/2023 |
NASONEX 24HR ALLERGY NDA #215712 |
SUPPL-15 |
MOMETASONE FUROATE |
PERRIGO PHARMA INTL |
Labeling |
Approval |
05/24/2023 |
TOFACITINIB ANDA #216940 |
ORIG-1 |
TOFACITINIB |
HEILONGJIANG ZBD PHARMACEUTICAL CO LTD |
|
Tentative Approval |
05/24/2023 |
ROCURONIUM BROMIDE ANDA #217034 |
ORIG-1 |
ROCURONIUM BROMIDE |
HIKMA |
|
Approval |
05/24/2023 |
METRONIDAZOLE IN PLASTIC CONTAINER ANDA #217665 |
ORIG-1 |
METRONIDAZOLE |
AMNEAL |
|
Approval |
05/25/2023 |
ULTRAVIST 150 NDA #020220 |
SUPPL-54 |
IOPROMIDE |
BAYER HLTHCARE |
Efficacy |
Approval |
05/25/2023 |
ULTRAVIST 240 NDA #020220 |
SUPPL-54 |
IOPROMIDE |
BAYER HLTHCARE |
Efficacy |
Approval |
05/25/2023 |
ULTRAVIST 300 NDA #020220 |
SUPPL-54 |
IOPROMIDE |
BAYER HLTHCARE |
Efficacy |
Approval |
05/25/2023 |
ULTRAVIST 300 IN PLASTIC CONTAINER NDA #020220 |
SUPPL-54 |
IOPROMIDE |
BAYER HLTHCARE |
Efficacy |
Approval |
05/25/2023 |
ULTRAVIST 370 NDA #020220 |
SUPPL-54 |
IOPROMIDE |
BAYER HLTHCARE |
Efficacy |
Approval |
05/25/2023 |
CLARITIN HIVES RELIEF REDITAB NDA #020704 |
SUPPL-41 |
LORATADINE |
BAYER HEALTHCARE LLC |
Labeling |
Approval |
05/25/2023 |
CLARITIN REDITABS NDA #020704 |
SUPPL-41 |
LORATADINE |
BAYER HEALTHCARE LLC |
Labeling |
Approval |
05/25/2023 |
ULTRAVIST (PHARMACY BULK) NDA #021425 |
SUPPL-36 |
IOPROMIDE |
BAYER HLTHCARE |
Efficacy |
Approval |
05/25/2023 |
CLARITIN REDITABS NDA #021993 |
SUPPL-23 |
LORATADINE |
BAYER HEALTHCARE LLC |
Labeling |
Approval |
05/25/2023 |
SUSTOL NDA #022445 |
SUPPL-10 |
GRANISETRON |
HERON THERAPS INC |
Labeling |
Approval |
05/25/2023 |
TOPIRAMATE ANDA #078235 |
SUPPL-32 |
TOPIRAMATE |
ZYDUS PHARMS USA INC |
Labeling |
Approval |
05/25/2023 |
TOPIRAMATE ANDA #078235 |
SUPPL-33 |
TOPIRAMATE |
ZYDUS PHARMS USA INC |
Labeling |
Approval |
05/25/2023 |
TOPIRAMATE ANDA #078877 |
SUPPL-22 |
TOPIRAMATE |
ZYDUS PHARMS USA INC |
Labeling |
Approval |
05/25/2023 |
TOPIRAMATE ANDA #078877 |
SUPPL-24 |
TOPIRAMATE |
ZYDUS PHARMS USA INC |
Labeling |
Approval |
05/25/2023 |
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE ANDA #203136 |
SUPPL-44 |
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE |
AMNEAL PHARMS |
Labeling |
Approval |
05/25/2023 |
PALONOSETRON HYDROCHLORIDE ANDA #205870 |
SUPPL-3 |
PALONOSETRON HYDROCHLORIDE |
SAGENT PHARMS INC |
Labeling |
Approval |
05/25/2023 |
EPTIFIBATIDE ANDA #206127 |
SUPPL-4 |
EPTIFIBATIDE |
EUGIA PHARMA |
Labeling |
Approval |
05/25/2023 |
BUDESONIDE ANDA #206623 |
SUPPL-3 |
BUDESONIDE |
DR REDDYS LABS SA |
Labeling |
Approval |
05/25/2023 |
BUDESONIDE ANDA #206623 |
SUPPL-4 |
BUDESONIDE |
DR REDDYS LABS SA |
Labeling |
Approval |
05/25/2023 |
BUDESONIDE ANDA #206623 |
SUPPL-9 |
BUDESONIDE |
DR REDDYS LABS SA |
Manufacturing (CMC) |
Approval |
05/25/2023 |
TRIAZOLAM ANDA #213003 |
SUPPL-1 |
TRIAZOLAM |
ZYDUS PHARMS |
Labeling |
Approval |
05/25/2023 |
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE ANDA #214065 |
SUPPL-5 |
CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE |
ALKEM LABS LTD |
Labeling |
Approval |
05/25/2023 |
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE ANDA #214930 |
SUPPL-9 |
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE |
ALKEM LABS LTD |
Labeling |
Approval |
05/25/2023 |
POSLUMA NDA #216023 |
ORIG-1 |
FLOTUFOLASTAT F-18 GALLIUM |
BLUE EARTH |
Type 1 - New Molecular Entity |
Approval |
05/25/2023 |
NITISINONE ANDA #216201 |
ORIG-1 |
NITISINONE |
ETON |
|
Approval |
05/25/2023 |
CARBOPROST TROMETHAMINE ANDA #216939 |
ORIG-1 |
CARBOPROST TROMETHAMINE |
EUGIA PHARMA |
|
Approval |
05/25/2023 |
PAXLOVID (COPACKAGED) NDA #217188 |
ORIG-1 |
NIRMATRELVIR; RITONAVIR |
PFIZER |
Type 1 - New Molecular Entity |
Approval |
05/25/2023 |
MARGENZA BLA #761150 |
SUPPL-5 |
MARGETUXIMAB-CMKB |
MACROGENICS INC |
|
Approval |
05/26/2023 |
ITRACONAZOLE ANDA #076104 |
SUPPL-24 |
ITRACONAZOLE |
SANDOZ |
Labeling |
Approval |
05/26/2023 |
METOPROLOL SUCCINATE ANDA #078889 |
SUPPL-14 |
METOPROLOL SUCCINATE |
REDDYS |
Labeling |
Approval |
05/26/2023 |
METOPROLOL SUCCINATE ANDA #078889 |
SUPPL-17 |
METOPROLOL SUCCINATE |
REDDYS |
Labeling |
Approval |
05/26/2023 |
LEVETIRACETAM ANDA #090981 |
SUPPL-3 |
LEVETIRACETAM |
HIKMA FARMACEUTICA |
Labeling |
Approval |
05/26/2023 |
LEVETIRACETAM ANDA #090981 |
SUPPL-4 |
LEVETIRACETAM |
HIKMA FARMACEUTICA |
Labeling |
Approval |
05/26/2023 |
LEVETIRACETAM ANDA #090981 |
SUPPL-6 |
LEVETIRACETAM |
HIKMA FARMACEUTICA |
Labeling |
Approval |
05/26/2023 |
LEVETIRACETAM ANDA #090981 |
SUPPL-8 |
LEVETIRACETAM |
HIKMA FARMACEUTICA |
Labeling |
Approval |
05/26/2023 |
LEVETIRACETAM ANDA #090981 |
SUPPL-9 |
LEVETIRACETAM |
HIKMA FARMACEUTICA |
Labeling |
Approval |
05/26/2023 |
LEVETIRACETAM ANDA #090981 |
SUPPL-12 |
LEVETIRACETAM |
HIKMA FARMACEUTICA |
Labeling |
Approval |
05/26/2023 |
TAFINLAR NDA #202806 |
SUPPL-26 |
DABRAFENIB MESYLATE |
NOVARTIS |
Labeling |
Approval |
05/26/2023 |
METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE ANDA #202870 |
SUPPL-15 |
HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE |
ALEMBIC |
Labeling |
Approval |
05/26/2023 |
METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE ANDA #202870 |
SUPPL-18 |
HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE |
ALEMBIC |
Labeling |
Approval |
05/26/2023 |
MEKINIST NDA #204114 |
SUPPL-28 |
TRAMETINIB DIMETHYL SULFOXIDE |
NOVARTIS |
Labeling |
Approval |
05/26/2023 |
OPSUMIT NDA #204410 |
SUPPL-24 |
MACITENTAN |
ACTELION |
Labeling |
Approval |
05/26/2023 |
ITRACONAZOLE ANDA #205724 |
SUPPL-5 |
ITRACONAZOLE |
PAR PHARM INC |
Labeling |
Approval |
05/26/2023 |
SEVELAMER HYDROCHLORIDE ANDA #206883 |
ORIG-1 |
SEVELAMER HYDROCHLORIDE |
MACLEODS PHARMS LTD |
|
Approval |
05/26/2023 |
ITRACONAZOLE ANDA #209460 |
SUPPL-4 |
ITRACONAZOLE |
TORRENT |
Labeling |
Approval |
05/26/2023 |
APIXABAN ANDA #210026 |
ORIG-1 |
APIXABAN |
AUROBINDO PHARMA LTD |
|
Approval |
05/26/2023 |
ITRACONAZOLE ANDA #212239 |
SUPPL-1 |
ITRACONAZOLE |
ANNORA PHARMA |
Labeling |
Approval |
05/26/2023 |
PRAMIPEXOLE DIHYDROCHLORIDE ANDA #212797 |
SUPPL-1 |
PRAMIPEXOLE DIHYDROCHLORIDE |
XIAMEN LP PHARM CO |
Labeling |
Approval |
05/26/2023 |
VASOPRESSIN ANDA #213205 |
ORIG-1 |
VASOPRESSIN |
FRESENIUS KABI USA |
|
Tentative Approval |
05/26/2023 |
VASOPRESSIN ANDA #213206 |
ORIG-1 |
VASOPRESSIN |
FRESENIUS KABI USA |
|
Approval |
05/26/2023 |
METFORMIN HYDROCHLORIDE ANDA #213320 |
SUPPL-2 |
METFORMIN HYDROCHLORIDE |
HARMAN FINOCHEM |
Manufacturing (CMC) |
Approval |
05/26/2023 |
DOLUTEGRAVIR, EMTRICITABINE and TENOFOVIR ALAFENAMIDE NDA #215448 |
ORIG-1 |
DOLUTEGRAVIR, EMTRICITABINE and TENOFOVIR ALAFENAMIDE |
AUROBINDO PHARMA USA |
Type 4 - New Combination |
Tentative Approval |
05/26/2023 |
INPEFA NDA #216203 |
ORIG-1 |
SOTAGLIFLOZIN |
LEXICON PHARMS INC |
Type 1 - New Molecular Entity |
Approval |
05/26/2023 |
TIMOLOL MALEATE ANDA #217343 |
ORIG-1 |
TIMOLOL MALEATE |
MICRO LABS |
|
Approval |
05/26/2023 |
ZINPLAVA BLA #761046 |
SUPPL-12 |
BEZLOTOXUMAB |
MERCK SHARP DOHME |
|
Approval |
05/26/2023 |
TEZSPIRE BLA #761224 |
SUPPL-3 |
TEZEPELUMAB-EKKO |
ASTRAZENECA AB |
|
Approval |
05/28/2023 |
AZITHROMYCIN ANDA #065246 |
SUPPL-30 |
AZITHROMYCIN |
PLIVA |
Labeling |
Approval |
05/28/2023 |
ALBUTEROL SULFATE ANDA #207857 |
SUPPL-8 |
ALBUTEROL SULFATE |
SUN PHARM |
Labeling |
Approval |
05/30/2023 |
DIAZEPAM ANDA #091076 |
ORIG-1 |
DIAZEPAM |
NOVEL LABS INC |
|
Approval |
05/30/2023 |
JENCYCLA ANDA #091323 |
SUPPL-8 |
NORETHINDRONE |
LUPIN LTD |
Labeling |
Approval |
05/30/2023 |
BANZEL NDA #201367 |
SUPPL-11 |
RUFINAMIDE |
EISAI INC |
Manufacturing (CMC) |
Approval |
05/30/2023 |
QUETIAPINE FUMARATE ANDA #202674 |
SUPPL-22 |
QUETIAPINE FUMARATE |
UNICHEM |
Labeling |
Approval |
05/30/2023 |
FINTEPLA NDA #212102 |
SUPPL-9 |
FENFLURAMINE HYDROCHLORIDE |
UCB INC |
REMS |
Approval |
05/30/2023 |
CISATRACURIUM BESYLATE ANDA #212190 |
SUPPL-2 |
CISATRACURIUM BESYLATE |
PIRAMAL HLTHCARE UK |
Labeling |
Approval |
05/30/2023 |
CISATRACURIUM BESYLATE ANDA #212190 |
SUPPL-4 |
CISATRACURIUM BESYLATE |
PIRAMAL HLTHCARE UK |
Labeling |
Approval |
05/30/2023 |
CISATRACURIUM BESYLATE ANDA #212432 |
SUPPL-1 |
CISATRACURIUM BESYLATE |
PIRAMAL HLTHCARE UK |
Labeling |
Approval |
05/30/2023 |
CISATRACURIUM BESYLATE ANDA #212432 |
SUPPL-3 |
CISATRACURIUM BESYLATE |
PIRAMAL HLTHCARE UK |
Labeling |
Approval |
05/30/2023 |
OBETICHOLIC ACID ANDA #214862 |
ORIG-1 |
OBETICHOLIC ACID |
APOTEX |
|
Approval |
05/30/2023 |
OBETICHOLIC ACID ANDA #214980 |
ORIG-1 |
OBETICHOLIC ACID |
LUPIN LTD |
|
Approval |
05/30/2023 |
OBETICHOLIC ACID ANDA #215017 |
ORIG-1 |
OBETICHOLIC ACID |
MSN |
|
Approval |
05/30/2023 |
MESALAMINE ANDA #216941 |
ORIG-1 |
MESALAMINE |
ENCUBE |
|
Approval |
05/30/2023 |
VEVYE NDA #217469 |
ORIG-1 |
CYCLOSPORINE |
HARROW EYE |
Type 5 - New Formulation or New Manufacturer |
Approval |
05/30/2023 |
SEMGLEE BLA #761201 |
SUPPL-7 |
INSULIN GLARGINE-YFGN |
MYLAN PHARMS INC |
|
Approval |
05/31/2023 |
CLARITIN NDA #021952 |
SUPPL-22 |
LORATADINE |
BAYER HEALTHCARE LLC |
Labeling |
Approval |
05/31/2023 |
NALOXONE HYDROCHLORIDE ANDA #070172 |
SUPPL-31 |
NALOXONE HYDROCHLORIDE |
HOSPIRA |
Labeling |
Approval |
05/31/2023 |
INJECTAFER NDA #203565 |
SUPPL-20 |
FERRIC CARBOXYMALTOSE |
AM REGENT |
Efficacy |
Approval |
05/31/2023 |
INJECTAFER NDA #203565 |
SUPPL-24 |
FERRIC CARBOXYMALTOSE |
AM REGENT |
Labeling |
Approval |
05/31/2023 |
CLARITHROMYCIN ANDA #203584 |
SUPPL-2 |
CLARITHROMYCIN |
HEC PHARM |
Labeling |
Approval |
05/31/2023 |
CLARITHROMYCIN ANDA #203584 |
SUPPL-5 |
CLARITHROMYCIN |
HEC PHARM |
Labeling |
Approval |
05/31/2023 |
CLARITHROMYCIN ANDA #203584 |
SUPPL-9 |
CLARITHROMYCIN |
HEC PHARM |
Labeling |
Approval |
05/31/2023 |
CLARITHROMYCIN ANDA #203584 |
SUPPL-13 |
CLARITHROMYCIN |
HEC PHARM |
Labeling |
Approval |
05/31/2023 |
CLARITHROMYCIN ANDA #203584 |
SUPPL-18 |
CLARITHROMYCIN |
HEC PHARM |
Labeling |
Approval |
05/31/2023 |
CLARITHROMYCIN ANDA #203584 |
SUPPL-20 |
CLARITHROMYCIN |
HEC PHARM |
Labeling |
Approval |
05/31/2023 |
PRAMIPEXOLE DIHYDROCHLORIDE ANDA #203615 |
SUPPL-3 |
PRAMIPEXOLE DIHYDROCHLORIDE |
ACTAVIS ELIZABETH |
Labeling |
Approval |
05/31/2023 |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM ANDA #203874 |
SUPPL-3 |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
DR REDDYS |
Labeling |
Approval |
05/31/2023 |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM ANDA #203874 |
SUPPL-4 |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
DR REDDYS |
Labeling |
Approval |
05/31/2023 |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM ANDA #203874 |
SUPPL-5 |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
DR REDDYS |
Labeling |
Approval |
05/31/2023 |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM ANDA #203874 |
SUPPL-6 |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
DR REDDYS |
Labeling |
Approval |
05/31/2023 |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM ANDA #203874 |
SUPPL-7 |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
DR REDDYS |
Labeling |
Approval |
05/31/2023 |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM ANDA #203874 |
SUPPL-12 |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
DR REDDYS |
Labeling |
Approval |
05/31/2023 |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM ANDA #203874 |
SUPPL-15 |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
DR REDDYS |
Labeling |
Approval |
05/31/2023 |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM ANDA #203874 |
SUPPL-16 |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
DR REDDYS |
Labeling |
Approval |
05/31/2023 |
PRAMIPEXOLE DIHYDROCHLORIDE ANDA #204518 |
SUPPL-6 |
PRAMIPEXOLE DIHYDROCHLORIDE |
ALEMBIC |
Labeling |
Approval |
05/31/2023 |
COTELLIC NDA #206192 |
SUPPL-6 |
COBIMETINIB FUMARATE |
GENENTECH INC |
Labeling |
Approval |
05/31/2023 |
LYNPARZA NDA #208558 |
SUPPL-25 |
OLAPARIB |
ASTRAZENECA |
Efficacy |
Approval |
05/31/2023 |
DAPSONE ANDA #212701 |
ORIG-1 |
DAPSONE |
AMNEAL |
|
Approval |
05/31/2023 |
PIRFENIDONE ANDA #212709 |
ORIG-1 |
PIRFENIDONE |
APOTEX |
|
Approval |
05/31/2023 |
GEFITINIB ANDA #212827 |
ORIG-1 |
GEFITINIB |
NATCO |
|
Approval |
05/31/2023 |
BUPROPION HYDROCHLORIDE ANDA #216800 |
ORIG-1 |
BUPROPION HYDROCHLORIDE |
ANNORA PHARMA |
|
Approval |
05/31/2023 |
NAPROXEN ANDA #216908 |
ORIG-1 |
NAPROXEN |
TULEX PHARMS INC |
|
Approval |